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Introduction: Multiple sclerosis (MS) is a chronic, autoimmune, and demyelinating disease 
of the central nervous system. Exercise has shown to be an effective treatment; however, those 
with MS often do not adhere to the recommended exercise guidelines. Our study investigated 
the feasibility of a remote exercise program embedded with behaviour change to increase 
exercise participation (primary outcome) and adherence among persons with MS and improve 
MS symptomatology and quality of life (secondary outcomes). Methods: Thirty-six adults 
with mild to moderate MS were stratified according to previous exercise levels and block-
randomised into one of three groups: Control, General Exercisers (GE, who were not 
previously engaged in 30 or more minutes of moderate-intensity aerobic exercise 2+ days/week 
and 30 or more minutes of resistance training on 2+ days/week), and Advanced Exercisers (AE, 
who were previously engaged in 30 or more minutes of moderate-intensity aerobic exercise 2+ 
days/week and 30 or more minutes of resistance training on 2+ days/week). A four-month 
online exercise program including aerobic, resistance, balance, and flexibility training was 
delivered to GE and AE. We assessed four aspects of feasibility – process (recruitment), 
resources (monetary cost), management (staff time), and scientific (outcomes). At baseline, 
four months, and five months participants completed questionnaires to assess all outcomes. 
Participants logged exercise sessions using online exercise diaries and undertook video 
coaching calls.  Clinical findings: GE (n=12) and control (n=12) participants increased their 
exercise participation, whereas AE (n=12) participants did not in 16 weeks (p =.06; GE, 
d=0.38, D=1.6 ; AE, d= -0.15, D=-2.9 ; CON, d=0.85, D=6; ‘D’ is change score). The 
adherence rate of coaching calls for the intervention was 92% for the GE and 83% for AE. 
Seventy-three per cent of GE and 38% of AE participants adhered to the prescribed exercise 
sessions. The total study intervention costs were AUD 1512.00, excluding projected personnel 





found that a remote exercise program embedded with behaviour interventions is feasible and 
safe for persons with mild to moderate MS and helps increase their exercise participation and 
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CHAPTER 1- LITERATURE REVIEW AND STUDY INTRODUCTION 
 
This literature review includes research articles and book chapters till January 2021 and involves 
searches from Murdoch university online library, PubMed, and Google scholar. It includes 
articles related to “multiple sclerosis”, “epidemiology of multiple sclerosis”, “exercise and 
multiple sclerosis”, “behaviour-intervention in multiple sclerosis”, “social cognitive theory”, 
“home-based exercise program for persons with multiple sclerosis”, and other similar terms.   
 
1.1 MULTIPLE SCLEROSIS (MS) INTRODUCTION 
 
Multiple sclerosis (MS) is a chronic autoimmune and demyelinating disease of the central 
nervous system characterised by focal lesions of the neural tissue that may lead to physical and 
cognitive impairment (1). The disease is more prevalent in high-income countries than low-
income countries, and there has been an increasing global prevalence of the disease by 10.4% for 
the last three decades (2). Recent studies suggest that there has been a worldwide increase in the 
number of people with MS – from 2.3 million in 2013 to 2.8 million in 2020 (3), and the current 
data from 2017 indicates the number of people living in Australia with MS is over 25000 (4). 
Globally, the mean age of MS diagnosis is 30-33 years, and the number of females living with 
MS is double that of the male MS population (3). In addition, studies show that the prevalence of 
MS varies with latitude gradient (5). For instance, in Australia, the regions which are farther from 
the equator (Tasmania) have almost twice the number of people living with MS as compared to 





48% have severe limitations in performing core activities (e.g., self-care, mobility, transport), 
62.5% have some employment restrictions, and 66.7% have a dependency on others for some of 
the everyday activities like walking. (5) The total costs for all persons with MS in Australia have 
increased by 41% ($1.24 billion to 1.75 billion) from 2010 to 2017 (6). 
 
The symptoms of MS are heterogeneous, but common symptoms include muscle weakness, 
fatigue, pain, walking problems, blurred vision, and cognitive and behavioural problems (7).  
John F. Kurtzke in 1983 provided the Expanded Disability Status Scale (EDDS) to quantify the 
disability and impairment caused by MS (8). The EDDS is reported by clinicians and is a ten-
point scale that ranges from zero to ten with 0.5 intervals for higher levels of disability, scores of 
0-4.5 represent persons who can walk without aid and scores from zero to seven are quantified 
as mild to moderate MS (9,10). Later, to allow patient self-reporting, researchers of the North 
American Research Committee on Multiple Sclerosis (NARCOMS) developed the Patient 
Determined Disease Steps (PDDS) for persons with MS (11). PDDS is a nine-point scale that 
ranges from zero (normal) to eight (bedridden) (11). Learmonth et al. in 2013 provided evidence 
for the validation of PDDS for determining disability level in persons with MS, and the PDDS 
scores are strongly correlated with EDDS scores and can be reported by the patients (12). 
 
The cause of MS is not well understood; most acceptable theories suggest that it is an autoimmune 
disorder that may be induced by viruses such as the human herpes virus-6, Epstein-Barr virus, 
and other infectious agents and non-infectious agents like Vitamin D deficiency (13). 
Pharmacological treatment of MS includes disease-modifying agents to minimise the relapses 





Neurology and the European Committee of Treatment of Research in Multiple Sclerosis (EAN 
and ECTRIMS), approved in 2018, for delivering disease-modifying agents to persons with 
multiple sclerosis - with 21 recommendations (14,15). As there is no curative treatment for MS, 
besides pharmacological treatment, MS symptoms are also treated by non-pharmacological 
interventions (16). 
Exercise is “a structured movement process that individuals consciously and voluntarily engage 
in and includes those activities that improve or maintain fitness and health” (17), whereas 
physical activity refers to “movement activities of daily living including work- and job-related 
activities, leisure time activities, and activities performed around the home” (17). There is 
mounting evidence that shows exercise and increased physical activity participation are beneficial 
for persons with MS (18), and exercise is beneficial in managing MS symptoms like fatigue 
(19,20), balance (21), cognition (18), fitness and mobility (19,22–25), depression (26,27), 
increased health-related quality of life and social participation (19,28–31). Despite the benefits 
of exercises and engagement in physical activities, studies indicate that persons with MS are 
engaged in an insufficient amount of physical activities (32,33). Further, the studies explore that 
exercise rehabilitation is wanted by persons with MS (34,35) and acknowledged by clinicians 
(36) and verified to promote physical activity participation by research (37). This indicates a 
robust clinical rationale and demand for better rehabilitation interventions by engaging persons 
with MS in exercises to increase their physical activity participation 
 
Further, studies that incorporated behaviour change interventions showed increased exercise and 
physical activity participation of their participants with MS (38–40). Several models and theories 





health belief model (41), theory of planned behaviour (42), social cognitive theory (43), self-
determination theory (44), transtheoretical model (45). These models have been used for 
changing the behaviour of persons with MS to live a healthy life, however for increasing exercise 
participation, the researchers used the core aspects of social cognitive theory, which incorporates 
self-efficacy, outcome expectations, goal setting and planning, facilitators and impediments 
(43,46–51).  
 
Also, there is a need for sustaining physical activity participation among persons with mild-to-
moderate MS for longer durations (52). To that end, it is necessary to deliver an online, remote, 
and home-based exercise protocol with behaviour interventions to persons with MS. 
Additionally, recent public health events, such as healthcare accessibility restrictions due to 
COVID-19, enhanced the use of remote delivery of the exercise and behaviour interventions. 
Furthermore, few studies included home-based exercise training programs and behaviour change 
techniques for increasing exercise participation in persons with MS by remote supervision  
(40,53). Therefore, completing feasibility studies in this area before large-scale trials is essential 
because they provide a more intensive view of the pros and cons of more extensive study (46,54). 
 
This narrative literature review highlights the benefits and safety of exercises for persons with 
multiple sclerosis and the use of behavioural change theory to increase exercise participation and 
overall physical activity participation. In addition, this review aims to focus on the importance of 






1.2 EXERCISE AND PHYSICAL ACTIVITY PARTICIPATION IN PERSONS WITH MS 
 
It was not until in late 20th century; researchers recommended that physical activity participation 
is indeed beneficial for persons with MS(55). Rampello et al. performed a randomised crossover-
control study on persons with mild to moderate MS, comparing eight weeks of aerobic training 
and neurological rehabilitation, increasing walking capacity, and investigating the effect on 
fatigue and health-related quality of life (56). Although the study showed an increased walking 
capacity in persons with MS by aerobic training, compared to neurological rehabilitation, there 
were no effects on fatigue and non-significant changes in health-related quality of life. The study 
was undertaken in the hospital setting, and the participants were crossed over the two 
interventions, i.e., aerobic training and neurological rehabilitation after eight weeks and between 
this eight weeks washout period, participants were not allowed to do the exercise (56). Moreover, 
there was a high rate of dropouts, and the study reported no feedback from the participants for 
the protocol, which questions the feasibility of the program and the need for a more graded 
protocol(56). A systematic review by Rietberg et al. showed a significant body of evidence 
supporting the use of exercise therapy for persons with MS (29). This review revealed that 
exercise is beneficial for persons with MS in improving strength and mobility, while there was 
little evidence for improvement of fatigue, cognition, and health-related quality of life factors 
(29). The systemic review direct future research of exercise for persons with MS and selection of 







1.3 BENEFITS AND SAFETY OF EXERCISE IN PERSONS WITH MS 
 
A review by Motl & Pilutti in 2012 summarised the benefits of exercise in persons with multiple 
sclerosis, concluding there was significant evidence supporting increased muscle strength and 
increased aerobic capacity, decreased fatigue, improved balance, and health-related quality of 
life. They found non-significant evidence for decreased depression and increased activities of 
daily living (30). Motl and Pilutti further focused on the participation of exercise in persons with 
MS, and reporting of adverse events, type, and duration of MS as baseline statistics. Latimer 
Cheung et al., in 2013, indicated that exercises are beneficial for improving aerobic fitness and 
strength of muscles in persons with mild to moderate MS and showed that exercises could help 
improve MS symptoms and health-related quality of life (19). To improve MS symptoms and 
quality of life and promote exercise prescription, Latimer Cheung et al. in 2013 provided 
evidence-based guidelines for aerobic and resistance activity at moderate intensity (10). A  review 
by Pilutti et al. in 2014 showed fewer reported adverse events in exercise training compared to 
control conditions, and  risk of relapse was lower in exercise groups compared to controls (57). 
The study provided evidence for safety in doing exercises for persons with mild to moderate 
multiple sclerosis. 
 
Presently, there is mounting evidence that shows exercise is one of the best rehabilitation 
strategies for persons with MS and exercise is beneficial in managing MS symptoms like fatigue 
(19,20), balance (21), cognition (18), fitness and mobility (19,22–25), depression (26,27) and 
health-related quality of life and social participation (19,28–31,58). A recent meta-analysis by 





fatigue, functionality, balance, and quality of life in persons with mild to moderate MS (59). The 
study by Dalgas et al. in 2020 identified the exponential increase in research in exercise in MS 
since 1990 (60). The study identified areas of expertise and directed future research areas for 
focusing on methods and outcomes of like “reporting outcomes”, “study methodology”, 
“adherence to exercise”, and others (60).  
 
1.4 GUIDELINES FOR PHYSICAL ACTIVITY AND EXERCISES IN MS 
 
Latimer-Cheung et al. proposed evidence-based guidelines for prescribing, promoting and 
monitoring aerobic and resistance activity in persons with mild to moderate MS (10). According 
to these guidelines, persons with mild to moderate MS (EDDS scores 0-7), who are 18-65 years, 
should perform 30 minutes of aerobic training, two times per week, and strength training for 
major muscle groups, two times per week (10). The researchers suggested that persons with mild 
to moderate MS would achieve fitness benefits like aerobic capacity and muscular strength by 
following these guidelines and would be able to maintain fitness for an extended period (10). The 
research by Latimer et al. was limited in generalising  progression of exercises and did not focus 
on special considerations that might be needed for prescribing exercises for persons with MS. 
(10)  
 
Further, Kim et al. in 2019 added advanced aerobic exercise guidelines (61) to the original aerobic 
and resistance exercise guidelines by Latimer-Cheung et al. in 2013 (10) for persons with mild 





engage in 10-30 minutes of aerobic training at moderate intensity, two-three days per week, and 
perform five-ten resistance exercises with one-three sets and 8-15 repetitions two-three days per 
week (61). The advanced aerobic guidelines recommend 30-40 minutes of aerobic training, five 
days per week, for those already involved in the exercises according to original guidelines (61). 
In addition, there are considerations like heat sensitivity, how to progress the exercise for the 
duration, frequency, and type of exercises and if the exercises are tolerable to persons with MS. 
These updated guidelines need to be evaluated and verified to use for clinical purposes.  
 
The recent study by Canning and Hicks in 2020 evaluated the effectiveness of original guidelines 
(10) for the potential benefits of aerobic and resistance activity on improving MS symptoms and 
health-related quality of life for persons with mild to moderate MS (58).  This study suggested 
that persons with mild to moderate MS should engage in at least 12-16 weeks of the exercise 
program to receive potential benefits like improved mobility, fitness, fatigue, and quality of life 
for long-term exercise adherence (58). However, the previous studies used an exercise protocol 
of longer duration (3 to 4 months) for exercise adherence (62). Recently, WHO (World Health 
Organisation) (63) considered the evidence for increased physical activity participation and 
reduced sedentary behaviour in people living with a disability (64). Therefore, to get specific 
outcomes similar to general individuals, WHO recommended physical activity guidelines 







1.5 EXERCISE ADHERENCE AMONG PEOPLE WITH MS 
 
WHO (World Health Organisation) (63) defines adherence as “the extent to which a person’s 
behaviour – taking medication, following a diet, and/or executing lifestyle changes, corresponds 
with agreed recommendations from a health care provider”(65). In addition, researchers define 
“exercise adherence as the extent to which a patient acts in accordance with the advised interval, 
exercise dose, and exercise dosing regimen”(66). Although substantial evidence suggests that 
exercise and physical activity participation are beneficial for persons with MS, research suggests 
that persons with MS are less engaged in the exercises and physical activities than non-diseased 
persons (67,68). 
 
1.5.1 Social cognitive theory (SCT) and exercise adherence of persons with MS 
 
Several models mentioned above have been used to change the behaviour of persons with MS to 
live a healthy life; however, one behavioural change theory often used to understand better 
exercise behaviour among persons with MS is SCT (43,46–51). Bandura’s SCT proposes that 
personal or cognitive and environmental factors interact and result in behaviour change, and these 
interactions are bi-directional(43,69). The bi-directional interaction between behaviour and 
personal factors like self-beliefs, psychological influences, biological constructs or cognitive 
factors like experiences from vicarious situations result in one’s behaviour change and vice versa 
(69). Further, bi-directional interaction exists between personal and environmental factors like 
social impacts and environmental constructs (69). The last bi-directional interaction is between 





environmental influences and vice versa (69). The diagram below explores this bi-directional 
interaction.               
                            
The schematisation of Triadic Reciprocal Determination in the Causal Model of Social Cognitive 
Theory by Albert Bandura in 2011(70). 
The core determinants of behavioural change in SCT are: (43) 
• Knowledge of risk factors of the disease and related healthcare individuals (43)- the person’s 
knowledge of disease and related risk factors can change one’s beliefs towards exercise 
behaviour.  
•  Self-efficacy (ability to control one’s health habits) (43)- person’s level of self-efficacy 
determines whether one can adhere to the changed behaviour or not. For example, high self-
efficacy is more likely to adhere to the exercises. Bandura postulated that self-efficacy could 
either directly influence the exercise habits or indirectly by changing outcome expectations, 
goal setting, facilitators or impediments for exercise behaviour (43).    
•  Outcome expectations can be physical, social and self-evaluative (43) – knowing the benefits 
of engaging in exercise behaviour could be related to higher adherence.   
• Goal setting (setting goals to achieve that behaviour) (43)- the knowledge of making realistic 
goals and achieving them motivates to sustain the exercise behaviour.    
• Perceived facilitators (identification of the things which help to promote that behaviour) (43)- 
the qualitative study by Learmonth and Motl in 2016 provided pieces of evidence from person 
with MS that common facilitators of exercise experienced by person’s with MS have been 





knowledgeable and motivated healthcare providers, MS role models, group exercises, and 
others (71). 
• Impediments (knowledge of barriers to exercise and ways to overcome those barriers) (43)- 
evidence suggests that the most common barriers to exercise experienced by persons with MS 
are lack of transport facilities, lack of disabled facilities, changes in weather and temperature, 
social stress, problems with money and finance, family problems, instability of symptoms, 
fatigue, pain, muscle weakness, and cognitive and behavioural problems (71). Furthermore, 
these perceived barriers are thought to negatively affect the exercise behaviour of person’s 
with MS (43,71). 
 
Given the utility of SCT in understanding the exercise behaviour of the general population, 
researchers have aimed to correlate determinants of SCT with an increase in exercise adherence 
among persons with MS (47,48). For example, a cross-sectional study on persons with relapsing-
remitting multiple sclerosis showed that self-efficacy was indirectly correlated with increased 
exercise and physical activity participation by increasing the self-evaluative outcome 
expectations and goal setting and decreasing impediments for exercise and physical activity (47). 
This study was the first to determine the correlation between SCT principles and exercise 
participation in persons with relapsing-remitting MS (a condition with an increase in disease 
symptoms and then followed by complete or partial recovery) and provided direction for future 
research.  However, the study showed statistically significant results only for indirect pathways 
of self-efficacy and physical activity via outcome expectations, goal setting and impediments and 
did not incorporate facilitators of exercise. And the results of this study were statistically 






Furthermore, an observational study based on SCT showed that self-efficacy and other 
determinants of SCT could be used to increase physical activity participation in persons with 
relapsing-remitting multiple sclerosis (48). However, unlike the study mentioned above, this trial 
focused not solely on self-efficacy components but incorporated the other determinants (outcome 
expectations, barriers, goal setting, and facilitators) and suggested a relationship between the 
determinants and exercise adherence. Additionally, these studies indicate the effectiveness of 
principles of SCT in improving exercise adherence among persons with MS. To that end, it led 
to the use of principles of SCT on increasing exercise adherence in persons with MS.  
 
Implementation of behaviour change interventions can thus assist in increasing exercise 
adherence in persons with MS. Suh et al. in 2015 performed a pilot trial using principles of SCT 
to increase exercise participation in persons with MS via non-supervised technology (39). In the 
study, behavioural change intervention was delivered via newsletters and phone calls to 
participants with mild levels of self-efficacy for six weeks. The study reported increases in levels 
of self-reported exercise participation in the intervention group over the control group.  However, 
there is no clear evidence on the duration required to achieve change and maintain change. The 
above-mentioned interventions have only been applied for short periods from eight to 12 weeks, 
and there is a need for comprehensive studies of more than 12 weeks to investigate the 







1.5.2 Internet-based delivery of SCT behaviour interventions 
 
Using internet-based mechanisms for delivering SCT behaviour change strategies (i.e. using 
password-protected websites, video and PDF files, online chat forums) resulted in a significant 
increase in self-reported physical activity participation in persons with MS (73). Thus, the study 
was powered in changing the behaviour of persons with relapsing-remitting MS towards physical 
activity participation and used core determinants of SCT via internet-based delivery of the 
protocol. However, there was no increase in the core components of SCT except goal setting, 
where only the walking component was changed in the intervention group as compared to the 
control group. Based on the above methods, subsequent research has focused on secondary 
outcomes of behaviour change, symptom management, health-related quality of life, and physical 
activity participation. This research showed decreased fatigue, depression and anxiety, and 
improved health-related quality of life in its intervention group, compared to the control; 
however, the results are not statistically significant, and the sample has limited characteristics of 
ambulatory females (74).  
 
1.5.3 Guidelines based exercise plus SCT based behaviour change studies 
 
A randomised control trial protocol, entitled Project ‘step it up’, was proposed for increasing 
walking capacity in persons with MS who could walk independently (50). The study protocol 
was to use principles of SCT in conjunction with exercise guidelines (by Latimer et al., 2013(10)) 
for persons with mild to moderate MS (50). The intervention group received both the exercise 





exercise intervention and controlled education on healthy diet and sleep. This pilot trial showed 
an increase in walking capacity in both groups, but the sustainability of the intervention was better 
tolerated in the exercise plus SCT group (24). The study used only mild to moderately disabled 
persons with MS with a low level of gait disability to increase their walking capacity.  
 
The secondary outcomes of the ‘step it up’ study showed changes in MS-related symptoms and 
SCT constructs (31). The improvements in MS-related symptoms were more remarkable in the 
intervention group than control; however, the changes were not statistically significant. This 
study’s authors suggested that future research should be focused on determining the effect of 
exercise guidelines on improving MS symptoms; the study used an exercise intervention for both 
groups, so the effect of recommended exercise guidelines on MS symptoms without behavioural 




1.6 REMOTE AND HOME-BASED DELIVERY OF EXERCISE PROGRAMS 
 
As needed, some persons with MS are not able to access health-care services due to several 
barriers. Some of the barriers, like transportation services, can be voided by providing remotely 
delivered home-based exercise programs, for example, via telehealth programs. The International 
Organisation for Standardisation defines a telehealth program as “a use of telecommunication 





over a distance”(75). Telehealth programs are essential to promote and deliver healthcare services 
to persons living in remote areas or who cannot benefit from live healthcare services (75). A 
recent study for teleconsultation for persons with MS indicated this was a feasible method of 
exercise delivery that was appreciated by the persons with MS (76). However, these services have 
the limitations to access the patient closely, but they are of great importance during emergency 
conditions like COVID-19. Combined, the aforementioned studies show that home-based 
exercise programs are generally safe, feasible, and valuable for persons with multiple sclerosis 
(77). 
 
1.7 FEASIBILITY OF EXERCISE STUDIES AND THEIR IMPORTANCE 
 
The CONSORT (The Consolidated Standards of Reporting Trials) 2010 statement defines 
feasibility studies are studies that examine “whether a future definitive randomised controlled 
trial can be done, should be done and if so, how”(78), whereas pilot studies are randomised or 
non-randomised controlled trials which are conducted at a smaller scale (78). Feasibility studies 
are essential before the primary large-scale studies because these studies provide in-depth 
knowledge of all aspects of the primary studies and provide information about the threats to the 
validity of the primary studies (54). There are four aspects of feasibility studies- process, 
resource, management and scientific outcomes (54). The CONSORT extension statement 
provides the importance of feasibility studies by stating that these studies provide information on 
whether a Randomised Controlled trial can be done or not and provide ways to do it (78). In 
prompt to this, feasibility studies have been conducted for a practical exercise intervention in 





activity and exercise behaviour in persons with MS (40,53,79), the feasibility of aerobic exercise 
intervention on influencing mood, cognition, and quality of life on persons with MS (36). 
Perhaps, these studies have not focused on all aspects of the feasibility, which are- process, 
resources, management, and scientific outcomes (16). Therefore, there is a need for feasibility 
studies that examine the feasibility domains thoroughly and provide a detailed structure for 
conducting the large-scale study. 
 
1.8 REMOTELY DELIVERED, HOME-BASED EXERCISE AND BEHAVIOUR CHANGE 
FEASIBILITY STUDIES 
 
Few home-based feasibility trials have both exercise and behavioural-based interventions. 
‘Project GEMS’ (guidelines for exercise in multiple sclerosis) was a feasibility trial, with an 
intervention of a four-month-long home-based exercise program (40). The randomised controlled 
feasibility trial was based on guidelines for exercise for persons with MS (by Latimer et al. 2013 
(10)) and SCT-based behaviour change on an American cohort with mild to moderate MS. The 
results of this study showed increased exercise participation of persons with MS who were in the 
intervention group, compared to the control group. The study directed future research towards 
testing other cohorts of persons and using more graded protocols (including the latest MS 
guidelines for exercise (61)) and broader inclusion criteria.   
Further, the feasibility and safety of Project GEMS prompted the use of similar procedures on 
the African-American cohort of persons (53). This study was a 3-month trial (unlikely the original 
GEMS trial, which was four months) and used similar feasibility metrics on the process, 





feasibility, and preliminary effectiveness of increasing exercise participation in the African 
American cohort of persons. However, the retention rate was low compared to the original Project 
GEMS, and the study used telephone coaching calls instead of video coaching calls. Table 1 
provides a summary of some feasibility studies.  
 
1.9 CONCLUSION AND FUTURE DIRECTION 
 
This literature review has identified the importance of exercise in the management of symptoms 
associated with MS.  The above literature review has discussed the importance of home-based 
exercise interventions in an MS population and the potential benefits associated with combining 
SCT principles for encouraging persons with MS to adhere to the exercise program. In 
conclusion, persons with MS need life-long exercise adherence for increasing their quality of life. 
The planned study will first to examine the feasibility of a home-based exercise program using 
the updated guidelines (by Kim et al. in 2019 (61)) and supported with behaviour change 
interventions, and thus future research in this area is recommended. 
1.10 CURRENT RESEARCH PROPOSAL 
 
The literature review above has indicated the global burden of MS and the vital role of evidence-
based exercise interventions. Despite the many benefits of exercise, a large proportion of persons 
with MS are not currently engaging in exercise at a level consistent with recommended guidelines 
(68). The above literature review indicates that few studies have investigated guideline-





is a need for a feasibility study that evaluates the preliminary effectiveness of the updated exercise 
guidelines in persons with MS. Our exercise program is based on the program adopted within the 
GEMS study (40), albeit with a different cohort. Following recommendations in Learmonth and 
Motl (54) and Tickle-Degnan (80), our research will provide insight into the feasibility of 
remotely delivered, online, home-based exercise training supplemented with behavioural 
modifications and its impact on exercise participation, MS symptoms and exercise adherence. 
Further, our study will provide insight into the management feasibility; by reporting on the time 
required by staff involved in the study, study costs and the skill level requirements of the staff 
associated with the study. Finally, the outcomes of our study will help inform further large-scale 






Table 1: Comparison of existing pilot and feasibility studies (which used exercise and SCT based behaviour intervention for exercise 
adherence) 
Study Participants Methods Outcomes 
Hayes et 
al.,2017(24) 
65 participants, physically 
inactive, able to walk 
independently, PDDS 0-3 
SCT- 10 weeks exercise plus SCT 
education, six group sessions and 
three telephone coaching calls 
CONTROL- Exercise plus 
attention control education  
68% SCT group and 50% CON group met the 
exercise guidelines for improving walking. 
    
Coote et 
al.,2017(31) 
Same as above Same as above  Secondary results on fatigue, depression, anxiety, 
strength, physical activity, 
SCT constructs and impact of MS. 
Learmonth et 
al.,2017(40) 
Fifty-seven with mild-moderate 
MS participants, age-18-64 
years, PDDS ≤3, relapse-free 
from 30 days, non-exercisers, 
PAR-Q score of 2 or less. 
 
Intervention- 16 weeks home-
exercise program. 
Aerobic training and resistance 
training according to physical 
activity guidelines(10) and six 
behavioural change video 
Results were on feasibility metrics -process, 
resource, management, and scientific outcomes. The 
primary outcome has a moderate increase in self-
reported exercise behaviour in the intervention group 
as compared to control. Secondary outcomes were 





coaching calls with SCT based 
newsletters.  
Control- Waitlist group, sent 
study materials after completion 
of the study. 
Tertiary outcomes were for MS symptoms and 





32 African-American adults 
with mild-to-moderate MS, 
Rest same as above. 
Intervention same as above but 
was adjusted to deliver for 
African-American persons with 
MS for three months. 
Results on feasibility metrics-process, resource, 
management, and scientific outcomes. The primary 
outcome was a large increase in self-reported 
exercise behaviour measured by GLTEQ (Godin 






1.11 RESEARCH QUESTIONS 
 
a) Is a randomised controlled trial of remotely delivered, online, home-based exercise 
training program for persons with MS based on the latest exercise guidelines and 
embedded with behaviour interventions feasible based on process, resource, 
management and scientific feasibility? 
b) What is the preliminary effectiveness of our intervention for improving exercise 
participation, MS symptoms and exercise adherence? 
c) How do participants receiving the intervention value (or evaluate) the intervention in 




a) A home-based feasibility trial with the latest exercise guidelines for persons with MS 
supported with SCT principles can be delivered remotely by health care professionals to 
persons with mild to moderate MS living in Australia. 
b) A home-based exercise training program with behaviour modifications will increase 
exercise participation, decrease MS symptoms, and increase exercise adherence in 
persons with mild to moderate MS. 







CHAPTER 2- MANUSCRIPT 
 
The following chapter is written as per the author guidelines of ‘Pilot and feasibility studies’, BMC 






















Delivering a remote exercise program embedded with behaviour change theory to persons with multiple 
sclerosis (MS): a randomised feasibility trial. 
AUTHORS  
Kaur I. a, Fairchild, T. J. a, c, van Rens. F. E.C.A. a, Baynton, S. a, Kiely, A.W. a, Paul, L. d, Learmonth, 
Y.C. a, b, c. 
 
INSTITUTIONAL ADDRESSES 
a. Discipline of Exercise Science, Murdoch University, Murdoch, WA, Australia 
b. Perron Institute for Neurological and Translational Science, Perth, WA, Australia   
c. Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Murdoch, 
WA, Australia 
d. School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK 
CORRESPONDING AUTHOR 
Dr Yvonne Learmonth 
PhD, PT 
Discipline of Exercise Science  
Centre for Molecular Medicine and Innovative Therapeutics, Health Futures Initiative 
Perron Institute for neurological and translational science, Murdoch University 










Background: Multiple sclerosis (MS) is a chronic, autoimmune, and demyelinating disease of 
the central nervous system. Exercise is beneficial for persons with MS, but those with MS often 
do not adhere to recommended exercise guidelines. Using a remote exercise program based on 
recommended general and advanced exercise guidelines for persons with mild to moderate MS 
and embedded with behaviour change, our study investigated to increase exercise participation 
(primary outcome) and adherence among persons with MS and improve MS symptomatology 
and quality of life (secondary outcomes). Methods: We conducted a feasibility study on thirty-
six participants (age: 43.3 ± 13.3 years; mean ± SD) with mild to moderate MS who were 
stratified according to previous exercise levels and block-randomised into one of three groups: 
Control (CON; n=12), General Exercisers, who were not previously engaged in 30 or more 
minutes of moderate-intensity aerobic exercise 2+ days/week and 30 or more minutes of 
resistance training on 2+ days/week), (GE; n=12), and Advanced Exercisers, who were 
previously engaged in 30 or more minutes of moderate-intensity aerobic exercise 2+ days/week 
and 30 or more minutes of resistance training on 2+ days/week) (AE; n=12). A four-month, 
remotely delivered, online exercise program including aerobic, resistance, balance, and flexibility 
training whose delivery was grounded on principles of behaviour change theory was delivered to 
GE and AE. Participants completed primary and secondary outcome questionnaires at baseline, 
four months, and five months (early follow-up). Participants logged exercise sessions using 
online exercise diaries and undertook video coaching calls. In addition, four aspects of feasibility 
– process (recruitment), resources (monetary cost), management (staff time), and scientific 
(outcomes) assessed.  Results: : GE (n=12) and control (n=12) participants increased their 





D=1.6 ; AE, d= -0.15, D=-2.9 ; CON, d=0.85, D=6; ‘D’ is change score). The adherence rate of 
coaching calls for four months intervention was 92% for the GE and 83% for AE. Seventy-three 
per cent of GE and 38% of AE participants adhered to the prescribed exercise sessions. The total 
study intervention costs were AUD 1512.00, excluding projected personnel costs. The total 
personnel time required for five months for the study was equal to 289 hours. Conclusions: We 
extrapolated that a remote exercise program embedded with behaviour interventions is feasible, 
safe, and efficacious for persons with mild to moderate MS but may be less effective for those 
who are already active. 
Trial registration: ANZCRT number ACTRN12619000228189p 















2.2 KEY MESSAGES REGARDING THE FEASIBILITY 
 
1. What uncertainties exist regarding the feasibility? 
We aimed to investigate the feasibility of a remotely delivered, online home-based exercise 
training program based on the updated exercise guidelines for persons with mild to moderate 
MS and embedded with behaviour change techniques to the persons with mild to moderate 
multiple sclerosis (MS). The primary outcome was to increase exercise participation, and 
secondary outcomes were to decrease MS symptoms, improve quality of life and increase 
exercise adherence. 
 
2. What are the key feasibility findings? 
The results of our study indicate feasibility, safety and preliminary effectiveness of remotely 
delivering an online, home-based exercise program embedded with behaviour change 
techniques to persons with mild to moderate MS. In addition, there was an increase in exercise 
participation and quality of life of the participants who were not currently engaged in the 
exercises to the recommended levels of guidelines. 
 
3. What are the implications of the feasibility findings for the design of the main study? 
Our study directs the future large trials for increasing exercise participation and improving 
quality of life for the persons with mild to moderate MS who are not involved in the 










Multiple sclerosis (MS) is a chronic autoimmune and demyelinating disease of the central 
nervous system characterised by focal lesions of the neural tissue that may lead to physical and 
cognitive impairment (1).  Globally, the mean age of MS diagnosis is 30-33 years, and recent 
estimates suggest the number of people with MS has increased from 2.3 million in 2013 to 2.8 
million in 2020 (3). In 2017, it was estimated that the number of people living in Australia with 
MS was over 25000 (4). Out of total persons with MS in Australia, 48% have severe core 
activities (self-care, mobility, transport) limitation, 62.5% have some employment restrictions, 
and 66.7% have a dependency on others for some of the everyday activities like walking. (5) The 
total costs for all persons with MS in Australia have increased by 41% ($1.24 billion to 1.75 
billion) from 2010 to 2017 (6). 
 
Exercise is “a structured movement process that individuals consciously and voluntarily engage 
in and includes those activities that improve or maintain fitness and health” (17). Physical activity 
refers to “movement activities of daily living including work- and job-related activities, leisure 
time activities, and activities performed around the home” (17). There is mounting evidence that 
shows exercise and increased physical activity participation are beneficial for persons with MS 
(18), and exercise is beneficial in managing MS symptoms like fatigue (19,20), balance (21), 
cognition (18), fitness and mobility (19,22–25), depression (26,27), increased health-related 
quality of life and social participation (19,28–31). To help promote exercise prescription, Latimer 





moderate intensity (10).  The guidelines for exercise prescription by Latimer Cheung et al. 
provided a solid foundation; however, they did not include details concerning appropriate work: 
rest durations, progression of exercise volume (duration and frequency), exercise tolerability or 
individual differences in heat sensitivity. More recently, Kim et al. in 2019 (61) provided 
advanced aerobic exercise guidelines to the original aerobic and resistance exercise guidelines by 
Latimer-Cheung et al. in 2013 (10) for persons with mild to moderate MS. These updated exercise 
guidelines require evaluation and validation in people with MS. However, prior to a large-scale 
trial, it is necessary to do a feasibility study to know the pros and cons of the large study and if a 
study can be conducted on a large scale and what are the essential considerations to conduct a 
study at a large scale (46,54). Further, research to better understand the benefits of exercise 
rehabilitation is wanted by persons with MS (34,35), and the importance of this is acknowledged 
by clinicians (36) and verified by research (37). 
 
Despite the benefits of exercises and engagement in physical activities, studies indicate that 
persons with MS are engaged in an insufficient amount of physical activities (32,33). 
Incorporating behaviour change interventions have been shown to increase exercise and physical 
activity participation of persons with MS (38–40). There are multiple behavioural change models, 
but the most widely used theory for increasing exercise and physical activity participation is the 
social cognitive theory (SCT) (43,46–51). Given the chronic nature of MS, there is a need for 
sustaining the physical activity participation of persons with mild-to-moderate MS  post-
intervention and follow-up (52). Further, persons with MS are not able to access health-care 
services due to some barriers (37). Some of the barriers like transportation services can be avoided 





improve the longer-term sustainability of an exercise-based intervention. A telehealth program, 
as defined by the International Organisation for Standardisation, “Telehealth is a use of 
telecommunication techniques for the purpose of providing telemedicine, medical education, and 
health education over a distance”(75). 
A recent study for teleconsultation for persons with MS deduced the feasibility of online delivery 
of telemedicine and is appreciated by the persons with MS (76). These studies directed the use of 
more efficient protocols to deliver exercise interventions remotely by using telehealth services. 
However, these services have limitations that cannot be nullified, but they are of great importance 
during emergency conditions like COVID-19. Moreover, fewer studies included a home-based 
exercise training program and behaviour change techniques for increasing exercise participation 
in persons with multiple sclerosis without supervision  (40,53). 
 
We aimed to investigate the feasibility, preliminary effectiveness and safety of a remotely 
delivered exercise program based on recommended general and advanced exercise guidelines for 
persons with mild to moderate MS (10,61) and embedded with behaviour change to increase 
exercise participation (primary outcome) and adherence among persons with MS and improve 
MS symptomatology and quality of life (secondary outcomes). We investigated the four aspects 
of feasibility- process (recruitment), resources (monetary cost), management (staff time), and 









Our project is remote delivery of a home-based exercise training program, based on 
recommended guidelines for general aerobic, general resistance and advanced aerobic exercises 
for persons with mild to moderate MS (10,61) and embedded with SCT principles for behaviour 
change towards exercise. Our study is an initial part of the BASE protocol, an exercise program 
that delivers current physical activity guidelines and principles of behaviour change (81). The 
BASE protocol is “Changing Behaviour towards Aerobic and Strength Exercise (BASE): design 
of a randomised, phase I study determining the safety, feasibility and consumer-evaluation of a 
remotely-delivered exercise program in persons with multiple sclerosis” (81), and only 
preliminary results are reported in this manuscript. 
 
2.4.1 Ethics approval 
 
The study has obtained ethical approval from the associated Institutional Review Board 
(Murdoch University 2019/021, the ethics approval letter is in Appendix 7). All participants 
provided online informed consent, consistent with the National Health and Medical Research 
Council’s National Statement of Ethical Conduct in Human Research. 
 
2.4.2 Trial Design 
 
We conducted a  feasibility study of a home-based exercise training program remotely delivered 





early follow-up. Figure 1 shows the CONSORT diagram of the study, which outlines the 
recruitment and randomisation process. The participants self-reported their previous exercise 
levels via a screening questionnaire during initial recruitment. We identified them as non-
exercisers, who were not engaged in 30 or more minutes of moderate-intensity aerobic exercise 
2+ days/week and 30 or more minutes of resistance training on 2+ days/week and exercisers, who 
were engaged in 30 or more minutes of moderate-intensity aerobic exercise 2+ days/week and 30 
or more minutes of resistance training on 2+ days/week. We grouped the non-exercisers as 
general exercisers (GE) and exercisers as advanced exercisers (AE). Based on this, they were 
block-randomised into general exercisers intervention group or a usual care control group and 
advanced exercisers intervention group or a usual care control group. The exercise training 
program for general and advanced exercisers was oriented according to the recommended general 
and advanced exercise guidelines for persons with mild to moderate MS, respectively (61). There 
were 24 participants (12 general exercisers and 12 advanced exercisers) in the intervention group 
and 12 participants in the usual care control group (2:1 ratio).  
 
2.4.3 Participants recruitment 
 
Participants were recruited from mid-January 2020 to mid-February 2020 from existing 
university databases who previously took part in the research and through the social media pages 
of MS Research Australia, MS Australia and associated State and Territory advocacy 
organisations. We provided participants with the study weblink and study email address for 
further study details. Interested participants were consented to and screened via the online form, 






The eligibility criteria for screening included were;1. Eighteen years or older, 2. Self-reported 
diagnosis of MS, 3. Relapse-free in the past 30 days, 4. Patient Determined Disease Step Score 
(PDDS) (82,83) of ≤4 (i.e., mild to moderate disability consistent with the recommendations in 
the guidelines for exercise in MS),  We excluded the participants from study participants who did 
not meet the inclusion criteria. We included our inclusion criteria in the recruitment material to 
make it easy for the participants to look for their eligibility. We checked the interested 
participants’ list three times to determine if any participant had done the screening survey two or 
more times; this ensured the correct number of eligible participants. After the online screening, 
interested and eligible participants were contacted via phone calls to confirm their participation. 
Non-eligible participants were thanked for their interest and asked if they would like to be notified 
of future research opportunities at the university and provided a link to MS Australia’s Wellbeing 
& MS resources. 
 
 2.4.4 Sample size 
 
The sample size of the feasibility was determined based on the previous study (40) by the 
corresponding author and the primary outcome measure of current exercise participation 
(GLTEQ)(40). The effect size F was 0.369, at 95% error (e.g., Alpha 0.05) for two groups. The 
total sample size required was n=24 (8 per group). The sample size of 36 participants was 
determined to split the intervention group into smaller groups (n=24 intervention (n=12 



























Opened online screening survey (n = 561) 
Did not complete online 
screening survey (n = 426) Assessed for eligibility (completed 
online screening survey) (n = 135) 
Excluded (n = 17) 
♦ PDDS >4 (n = 7) 
♦ Recent relapse (n = 9) 
♦ Invalid survey return (n = 1) 
Met inclusion criteria (n = 118) 
Exercisers (n = 25) 
Non-Exercisers (n = 93) 
Exercisers randomly 
selected (n = 18)** 
*Note: 4 more participants were 
randomly selected but did not 
respond to communication about 
their allocation. 
Non-Exercisers randomly 
selected (n = 18)* 
Randomized (n = 36) 
**Note: 3 more participants were 
randomly selected but did not 
respond to communication about 
their allocation. 
1 participant was no longer interested 
in the intervention. Allocation 
Allocated to control (n = 12 [6 from 
each group]) 
Allocated to Advanced Exerciser (n = 12) Allocated to General Exerciser n = 
12) 
Lost to follow-up after 4 months (n =2): 
n=1 (personal reason), 
n=1 (neurological symptoms) 
Shifted from GE group, n=1 
 
Lost to follow-up after 4 
months (n=2): 
n=1 (personal reason),  
n=1 (shifted to AE and was 
analysed in it. 
 
Lost to follow-up after 4 months (n = 
2): 
 n=2 (personal reason) 
Lost to follow-up after 5 months (n=3): 
n= 2 (personal reason), 
n=1 (not analysed because of 
pulmonary embolism) 
Lost to follow-up after 5 months 
(n = 0) 
 
Lost to follow-up after 5 months, n = 1 
(personal reason) 
Analysis 







A researcher not associated with program delivery or outcome assessment used a computer-
generated block-randomisation process to select participants for participation, out of all interested 
and eligible participants (n=118, (n=93 non-exercisers and n=25 exercisers)), 36 participants 
(n=18 non-exercisers and n=18 exercisers) were randomly selected to confirm their participation 
via telephone calls (four more exercisers and four more non-exercisers were randomly selected 
but did not respond to communication with the research staff).  
 
We provided participant deidentified identification (ID) codes to the participants and asked them 
to complete the online baseline assessment via questionnaire through Qualtrics (a survey software 
tool (Qualtrics©, Provo, UT (84)). We gathered the data during the first two weeks in April 2020. 
An initial 36 participants were invited to complete baseline measurement; however, two 
participants did not respond to telephone calls to confirm group allocation and were not included 
in the study. We then invited two other participants from the randomised pool of potential 
participants. All participants were randomly allocated by a researcher not associated with 
intervention delivery of outcome measurement (e.g., blinded randomisation). Participants were 
then telephoned about their group allocation, for the detailed information of the study, for their 
questions related to the study. In addition, they were informed about the postage of exercise 
equipment (a pedometer and a set of elastic resistance exercise-bands [Progymnasium, 
ResibandsTM, NSW, Australia], Appendix 5_Figure 1 and Appendix 5_Figure 4 of exercise 








The research staff, including senior research staff, the neurological physiotherapist (YL), exercise 
physiologist (TF) and exercise psychologist (FvR) and the junior researchers (IK, SB, AwK), 
developed the intervention, and neurological physiotherapist (LP) developed the exercise videos.  
 
Staff training: 
The senior research staff provided training to the junior research staff on developing the exercise 
program, software use and SCT based behavioural e-newsletters and coaching calls. These staff 
trainings were held by live and online meetings between research staff during the intervention. 
The senior staff explained SCT based behaviour change techniques to coaches and how to 
implement behaviour principles during the intervention. A graphic designer (OC clothing, Perth, 
WA) also helped in developing e-newsletters. Figure 2 shows the study flow. 
 
Our exercise training program was remotely delivered and structured with resistance training, 
aerobic training, balance, and flexibility training exercises based on the original (10) and updated 
exercise guidelines (61). The intervention is to deliver behaviour video coaching calls grounded 
on SCT principles for behaviour change and to keep track of their exercises. The behaviour 
coaching calls were semi-scripted and were based on e-newsletters. The resistance training 
consisted of 1–2 sets, 10–15 repetitions of 10 exercises targeting the lower body, upper body, and 
core muscle groups two days per week for GE and AE based on prescribed guidelines for persons 





further, their progression was tailored to participants. We asked the participants to complete these 
exercises with the help of elastic resistance bands of different levels of resistance. 
 
Table 2 outlines the prescribed exercises with their levels of difficulty. All participants completed 
walking, and five core resistance exercises (i.e., walking, seated arm row, press-up, calf raises, 
squats and hamstring curls in standing) progressed to one balance, one flexibility and eight 
resistance exercises by week 13 of the program. The participants were provided with the online 
Giraffe healthcare portal for viewing the exercise videos and for progressions and regressions of 
exercise. The program followed the same structure for all participants in the first two weeks, and 
then progression varies as described in table 3. The exercise program offers three levels of 
difficulty (red, most difficult; black, medium-difficult; and white, least difficult). Participants 
chose levels of difficulty based on clinical discussion with their respective coaches on the level 
of difficulty in the initial two weeks of the exercise program and barriers to exercises. We added 
the balance and flexibility exercises into the program at week five, and participants were asked 
to do balance exercises (heel and toe walking) for two days per week and flexibility exercises 
(mild stretches) before and after resistance exercises.  
 
Participants in the GE group completed two sessions of resistance training and aerobic training 
per week for 16 weeks and two sessions of balance exercises, flexibility exercises per week for 
12 weeks. Participants in the AE group completed two sessions of resistance training, five aerobic 
training sessions per week for 16 weeks, and two sessions of balance exercises and flexibility 












































Recruitment and Screening 
 
Murdoch Database and Third-party collaborators social media pages 























Week 1: Participants initiated exercise program; Week 2: E-
newsletter one on ‘Outcome Expectations’; Week 3: Video 
coaching call one; Week 4: E-newsletter two on Self-
monitoring  
Week 5: Video coaching call two, Manual two (with added 
exercises), Balance and Flexibility exercises added to Giraffe 
program; Week 6: E-newsletter three on ‘Goal-setting’; Week 
7: Video coaching call three, Week 8: Break  
 
Week 9: E-newsletter four on ‘Self-efficacy’, Two additional 
resistance exercises added to the Giraffe program; Week 10: 
Video coaching call four; Week 11: E-newsletter five on 
‘Overcoming barriers’; Week 12: Video coaching call five 
Week 13: One more additional resistance exercise added to the 
Giraffe program; Week 14: E-newsletter six on ‘Identifying 
facilitators’; Week 15: Video coaching call six; Week 16: Break 
Intervention 
Introductory calls for group allocation and study information were done for all 
participants. Exercise equipment were posted to the GE and AE group and Giraffe 
program was set up for GE and AE group. 
 
 
Week 17: Post-intervention data-collection 





Table 2: Prescribed exercises with rationale 
S.no. 
Basic Exercises 




It is an aerobic exercise which is 
useful for increasing 
cardiovascular fitness of persons 
with mild to moderate MS. 
It was progressed from 10-30 
minutes for GE two times a 
week and 10-40 minutes at 
moderate intensity for five times 
a week. 
B. Resistance exercises 
   
1 Squats 
It is a fundamental exercise for 
lower limb strengthening, which 
can be done by persons with 
mild to moderate MS. It helps 
get in or out of the chair and for 
activities of daily living.  
It could be progressed from 
squats to squat intermediate -
squat advanced- unilateral squat. 
2 Calf raises 
 
It is a strengthening exercise for 
gastrocnemius and soleus 
muscle. It helps maintain muscle 
mass of calf muscle and 
neuropathic condition (foot 
drop) for persons with mild to 
moderate MS. 
It could be progressed to single 
leg calf raises- calf raises 
advanced (without support). 
3 Hamstring curls in standing 
 
It is a strengthening exercise for 
hamstring muscle which helps 
climb stairs and assist hip 
extension.  
 
It could be progressed to 
hamstring curls in standing with 
resistance band- bridging- 
bridging advanced. 




It is strengthening exercise for 
pectorals, shoulder muscles and 
abdominals. They are easy to do 
at home for shoulder joint 
stabilisation by persons with 
mild to moderate MS and 
helpful in activities of daily 
living. Pectorals also assist in 
breathing. 
It could be progressed to press 





5 Seated rows with resistance band 
 
It is upper back muscles 
(rhomboids and trapezius) 
strengthening. Helpful in 
forward-reaching daily activities 
and maintaining posture for 
persons with mild to moderate 
MS. 





in Week 4 
   
6 Heel-toe walking 
It is a balance exercise which 
helps in maintaining balance 
while walking. Balanced 
walking is the primary concern 
for persons with mild to 
moderate MS. It is suitable for 
neuroplasticity in persons who 
have mild symptoms of MS. 
It could be progressed to heel-
toe walking advance (without 
support). 
7 Cooldown stretches 
These are mild stretching 
exercises for the upper and 
lower body. This help maintains 
flexibility and range of motion 
of the joints and relaxing the 
muscle, i.e. helpful in reducing 
spasticity in persons with MS. 
These could be progressed to 






   
8 Lunges 
 
Functional exercise, for 
strengthening quads and glutei 
and for increasing balance. 
 
It can be progressed to do lunges 







            
 
           9 
Hip extension 
strengthening in  
standing with  
resistance band 
 


















exercise    
 
Getting up and  
down from  
the floor 
It is a functional training 
exercise which is helpful for 
persons with mild to moderate 
MS for doing floor activities.   
 
Aerobic training consisted of walking at moderate intensity, which was determined via step count 
by participants. We asked participants to wear pedometers, or they could use the mobile app for 
step-counting to maintain walking intensity.  
 
Furthermore, we asked participants to check their stepping rate after every 5 minutes of walking 
and try to maintain 1000 steps per 10 minutes or 500 steps per 5 minutes (at moderate intensity) 
(85,86). For general exercisers, the walking prescription was started at 10 minutes and progressed 
to 30 minutes for two days per week. For advanced exercisers, the walking prescription consisted 





Table 3: Progression table for General and Advanced Exercisers 
    General Exerciser           
Advanced 
Exerciser         















RE   
Two 
times per 




















































































































































































































































































































































































































Note: Bold letters indicate the participants reaching the exercise guidelines (61). AW= Aerobic exercise (walking); RE= 





We provided participants with the Rate of Perceived Exertion (RPE), a standard scale of 6-20 
(87) with their exercise program and also asked them to report sets and reps of each exercise, 
sessions of resistance training, duration of walking, step count during walking and sessions of 
walking via online exercise diaries on Giraffe healthcare portal. We also asked them to report 
RPE for prescribed exercises and walking sessions. Coaches reminded them to complete the 
exercise diaries during coaching calls and via text message reminders. The participants received 
the following intervention materials: 
 
a.) Exercise manuals (Example in appendix five): Participants received exercise manuals in PDF 
format via email. We developed twos set of exercise manuals; one set for general exercisers, 
which contained information about their exercise prescription as per original guidelines,(10) 
and another set for advanced exercisers, which contained information about their exercise 
prescription according to updated guidelines (61). Both sets of manuals contained information 
on safety with home exercise, the exercise equipment, the exercise website, exercise photos, 
exercise instructions, and explanations on the use of the rating of perceived exertion (RPE) 
scale. Additionally, the manuals contained information about support services like Beyond 
Blue (http://www.beyondblue.org.au/). Participants were sent updated manuals with 
flexibility, balance, and additional resistance exercises at the end of the first month.  
 
b.) Online individualised exercise portal: We provided participants with a study-specific and 
password protected online exercise program via Giraffe Healthcare 
(https://www.giraffehealth.com/), a physiotherapy designed exercise program hosted by 
collaborators at Glasgow Caledonian University, UK. This program allowed participants to 





program were from the range of whole-body exercises (Table 1) and were based on the 
progression of exercises as in table 2.  We asked the participants to complete the online 
exercise journal/diaries available at the Giraffe Healthcare portal after completing the 
exercise. 
 
c.) E-newsletters: We emailed six e-newsletters over 16 weeks to the participants, more 
frequently at the start, hence at every two- or three-week interval. Each newsletter draws 
attention to SCT topics in the following order: outcome expectations, self-monitoring, goal 
setting, self-efficacy, overcoming barriers and identifying facilitators. The layout of each 
newsletter includes an explanation of the topic concerning MS maintaining ongoing exercise 
behaviours, topic-relevant “experience-stories” from other people with MS who have 
benefitted from exercise, topic-relevant written tasks for participants, and website links to 
topic-relevant online content. The topic relevant tasks were to encourage learning of essential 
principles for understanding, changing, and maintaining. Tasks encouraged participants to 
apply the information to their situation, analyse connections between the information and 
contrast its relevance to their past, current and future circumstances (88). After receiving e-
newsletters, participants received a one-to-one coaching call. 
 
d.) Coaching calls: We delivered the introductory calls to the participants through telephone calls 
(voice calls), which included safety, equipment, and structure of the exercise training 
program. Then, six SCT video coaching calls in weeks 3,5,7,10,12 and 15 were delivered to 
the participants. The coaches (one is a final year student of Clinical Exercise Science, one is 
an AEP and student of Master of exercise science, and one is a student of Master of Exercise 





to the participants according to their preferred video call platforms (e.g. Zoom, Whatsapp, 
Facetime) to monitor exercise prescription and implement principles of behaviour change. 
The coaching calls followed a semi-structured scripted (appendix four) content for 
consistency between coaches. Coaches discussed the behaviour change principles according 
to the respective e-newsletters and the learning tasks of the e-newsletters. Besides, coaches 
examined and demonstrated the correct technique to do the prescribed exercises. Coaches 
also prescribed the progression and regression of exercises based on clinical discussion with 
the participant (i.e. shared decision making) and subsequent discussion with senior 
researchers (YL and TF).  
 
e.) Reminder text messages: On the weeks when coaching calls did not occur, participants 
received reminder text messages to encourage adherence and compliance with the program.  
 
f.) Exercise equipment: We asked the participants to use the posted elastic resistance exercise 
bands and pedometer for the prescribed exercise program. 
 
g.) Safety: During the first video coaching calls, coaches discussed the safe environment to do 
exercises. During video coaching calls, coaches asked the participants if they had suffered 
from any adverse event during the intervention time. In case participants had any adverse 
events, coaches reported it to the research staff (table 6). The safety data were also recorded 







h.) Control group: The control participants were asked to perform their usual activities to 




Following recommendations in Learmonth and Motl (54)  and in Tickle-Degnan (80), we have 
collected data on four aspects of feasibility metrics  -process (e.g. recruitment), resources (e.g. 
adherence, communication, and monetary cost), management (staff skills and time, data 
management), and scientific (primary and secondary outcomes). Table 4 provided the details of 
feasibility metrics. We collected the scientific outcomes via the Qualtrics software tool (84) and 
provided a unique survey ID to enter each time point to the participants. Furthermore, questions 
on date of birth and year of diagnosis were collected at all time points. These measures were to 
confirm participant data between surveys at different time points. All data were self-reported. We 
collected the outcomes at baseline, after four months (post-intervention) and after five months 
(early-follow up). All data were downloaded from the server and stored on password-protected 
computers of the research team. 
 
The primary outcome measure of exercise participation was measured by the Godin Leisure-Time 
Exercise Questionnaire (GLTEQ) (89). GLTEQ is a validated self-reported questionnaire for 
measuring leisure-time exercises and can be used to implement an exercise program (90). The 
tool includes four questions to determine seven-day participation in strenuous exercise, moderate 
exercise, and mild exercise. The fourth question asks participants how many sessions of strenuous 





Table 4: Feasibility table 
Metric  Outcomes assessed Measurement method 
Process 
feasibility  Recruitment rate  
The total number of participants who consented for 
the study out of the total number of participants who 
opened the recruitment survey site. 





The total number of eligible participants out of the 





The number of participants who refused participation 




feasibility  Retention rate 
 
The total number of participants completed the post-
intervention (month 4) and early follow-up (month 
5) questionnaires.  
  
Reported barriers to the 
participation 
Notified the reasons for participants lost during 
follow-up and participants' discontinuation to the 
study during intervention time.  
  Adherence rate 
The total number of exercise sessions and video 




It was assessed by the feedback questions in 
questionnaires on 'length of survey' and 'happy to 
answer all questions' during each assessment of the 
participants.  
  Monetary cost 





Initial screening calls, introductory calls, and video 




The total number of meetings held between the staff 
members for junior staff training, data analysis and 




feasibility  Ethics approval time 
Time taken to get ethics approval from the 
Institution. 
  Staff skills 
The education and experience of the staff involved in 
the study. 
  Staff time for the study 
Time for research material preparation, equipment 
choosing and purchasing, recruitment, 
randomisation, staff meetings for training, 
introductory calls to the participants, video coaching 





  Equipment usage 
The use of pedometers and resistance exercise bands 
by the participants.  
  
Processing time for data 
collection 
The mean time taken by the participants for 




This was recognised the use of Qualtrics software by 






feasibility  Safety 
Safety was measured by the reporting of any adverse 
events of the participants during video coaching calls 






compliance to the 
intervention 
Exercise adherence was measured by the total 
number of exercise sessions attended by the 
participants. And video coaching call adherence was 
measured by the total number of video coaching 
calls attended by the participants. Compliance was 
measured by the number of sets, reps and exercises 







GLTEQ measured primary outcome measurement of 
exercise participation, Secondary outcome 
measurement of MS symptoms and quality of life 
was measured by appropriate scales provided in 
table 8.  
  
 
Acceptability of the 
intervention 
Feedback of the participants to the intervention 




of the intervention 
It was assessed during follow-up questionnaires via 
questions on suitability, acceptability, and 
appropriateness of the intervention. 
 
 
Scores are calculated from the first three questions using the established protocol (89,90). The 
protocol calculates the frequency of engaging in strenuous, moderate, and mild exercises for at 
least 15 minutes in seven days (90).  The first question is for strenuous exercises times per week 
multiplied by the metabolic equivalent of nine; the second question is for moderate exercises 





(90). Then, the scores are summed to get the leisure score index. We asked participants to report 
on all forms of exercise they participated in when responding to the GLTEQ. The following scales 
measure the secondary outcomes and their measurements- 
 
The exercise-related social-cognitive factors associated with adherence were measured by 
Exercise Self-Efficacy Scale (ESES) (91) measures the self-efficacy of the person, which is a 
useful tool for influencing behaviours (92). The six items in the scale assess the participant's 
beliefs to engage in moderate to vigorous physical activity for 30 or more minutes for the next 
six months. The response to each item measures the participant's confidence to engage in 
moderate to vigorous physical activity for the next month, following two months, three months, 
four months, five months, and six months, from 0% to100 %. The 6-item ESES is consistently 
shown to correlate with predictors of physical activity in MS and is a reliable tool for persons 
with MS (92).  Higher scores indicate a higher level of self-efficacy (91). 
 
Exercise Goal Setting and Planning Scale (EGSPS) is a reliable tool for measuring the relation 
between social cognitive variables (like self-regulation) physical activity (49). There are two parts 
of the scale- Exercise goal setting and Exercise planning scale, and there are ten items in each 
part. These ten items are rated from a 0-5 scale where zero indicates ‘does not describe’ and five 
indicates ‘describes completely’(49). Item two, three and seven of the Exercise planning scale is 
reversely scored, and the rest of all items of both scales are positively scored. The higher scores 






The Psychological Need Satisfaction in Exercise Scale (PNSES) measures the satisfaction for 
exercises, and the 18-item scale has six items for every three sub-scales -competence, relatedness 
and autonomy, which are intermixed (93). For example, “I feel that I am able to complete 
exercises that are personally challenging.” and the response ranges from 1=false to 6=true (93). 
PNSES is a valid and reliable tool for measuring psychological constructs for exercise, and its 
higher scores indicate more motivation towards exercise (93,94).  
 
We measured mobility using the Multiple Sclerosis Walking Scale-12 (MSWS). This scale 
consists of 12 items that describe the impact of MS on walking and was generated by interviewing 
patients, the opinions of experts and literature review (95). For example, “In the past two weeks, 
how much has your MS… Limited your ability to walk?” and the response ranges from 1=not at 
all to 5=extremely. This scale is reliable for measuring walking ability in MS, and higher scores 
indicate more limitations for walking (96).  
 
The balance was measured by the Activities-Specific Balance Confidence Scale (ABC), which 
has 16 items used to measure an individual's confidence in performing his/her daily activities 
without falling (97). For example, “How confident are you that you will not lose your balance or 
become unsteady when you… walk around the house?” and the response is on a Likert-type scale 
from 0% to 100% (97). The higher scores indicate more confidence in daily activities (97). ABC 






We measured fatigue by the Fatigue Severity Scale (FSS). Krupp et al., in 1989, developed this 
scale to know the severity of fatigue in MS patients and systemic lupus erythematosus, and the 
study showed higher scores for MS patients than average healthy persons (99). The nine-item 
FSS has items related to the previous week, like, “My motivation is lower when I am fatigued.” 
The responses are on a seven-point scale range from 1=strongly disagree to 7=strongly agree 
(99). In 2013, Learmonth et al. established that FSS is a moderately reliable and validated tool 
for measuring physical aspects of fatigue in persons with MS (100). 
 
We used the Hospital Anxiety and Depression Scale (HADS) by Zigmond and Snaith in 1983 to 
measure some symptoms of anxiety and depression (101). There are two subscales of the 14-item 
HADS scale- HADS anxiety subscale (HADS-A) and HADS depression subscale (HADS-D) and 
there are seven items for each subscale which are intermixed, and the responses vary on a four-
point scale (range from zero to three) (102). The14-item HADS is a validated tool for measuring 
depression and general anxiety symptoms at the initial level in persons with MS (103). The scores 
of both subscales of HADS are totalled separately, and cut-off scores for quantification are 
interpreted as; 0-7 normal, 8-10 mild anxiety or depression, 11-14 moderate anxiety or depression 
and 15-21 severe anxiety or depression (102).  
 
Leeds MS Quality of Life Scale (LMSQOL) is used disease-related quality of life (104). LMSQOL 
has eight items like, “My health has affected my relationships with my family.” The responses 
range from 0=not at all to 3=very much, and the total score is obtained by summing the eight 





et al. validated LMSQOL as a reliable tool to measure the quality of life in persons with MS, and 
higher scores of Leeds indicate the worse quality of life (98).  
 
2.4.8 Demographic and clinical descriptors 
 
We gathered demographic information on age, sex, employment, and clinical disability level 
using the Patient Determined Disease Steps (PDDS) (82). PDDS has been shown to correlate 
positively with clinically determined disability (83). We also gathered information on years since 
diagnosis, MS-type at diagnosis, use of disease-modifying therapies, and symptom modifying 
therapies. 
 
2.4.9 Data management and analysis 
 
a.) Feasibility metrics  
We reported and analysed the process feasibility (e.g. recruitment), and management feasibility 
outcomes (staff skills and time, data management) where relevant, as total counts and means (SD) 
or as percentage rates and counts. Resource feasibility outcomes (e.g. adherence, communication, 
and monetary cost) were analysed as percentage rates and counts. For scientific outcomes data 
(primary and secondary outcomes), participants entered scientific outcomes data via 
questionnaires at baseline, four months, and five months directly into the Qualtrics online survey 
site. The research staff then downloaded the data directly from the website and cleaned it for 






b.) Adherence and compliance 
The participants had reported their exercise sessions on the online Giraffe healthcare site. For the 
GE group, median adherence was 50 sessions (IQR 21 sessions), and for the AE group, median 
adherence was 64 sessions (IQR, 50 sessions). For comparison and consistency with previous 
research (53,58,79), we also reported the participants who attended ≥70% of the total exercise 
sessions and participants who attended ≤70% of the total prescribed exercise sessions as non-
adherence. In our analyses, we included the prescribed aerobic and resistance sessions as primary 
adherence rate and prescribed aerobic (i.e., duration of the walk, number of steps, Rating of 
Perceived Exertion (RPE), 6-20 scale (87))  and prescribed resistance exercises in our reporting 
of compliance to meet the exercise guidelines. We also reported adherence to balance and 
flexibility exercises as prescribed and used ITT analysis protocol (intention to treat analysis) for 
our outcome measures.   
 
c.) Feedback and intervention evaluation 
The outcome assessment reaction was measured as a feedback question for the length of the 
questionnaire and participants reaction to all questions (e.g., happy to answer or not) at the end 
of each questionnaire at all three-time points. In addition, we reported the participants’ evaluation 
of our intervention regarding suitability, acceptability, and appropriateness of the program for 
future improvements. Appendix six contains the questions related to participants evaluation of 
the intervention. We measured the outcomes via Qualtrics software, which was set to require all 






          
2.5.1 Demographic characteristics 
 
Table 5 depicts the demographic details of the participants in the three groups. There was a greater 
number of females than males in the study (M: F; 2:34). The mean age of the sample was 43.28 
(±13.28), and the mean years since diagnosis of MS were 7.5 (±6.5). The median PDDS score of 
the sample was 1. Thirty-four participants had RRMS (Relapsing-Remitting Multiple Sclerosis), 
and only two participants had PPMS (Primary Progressive Multiple Sclerosis). Seventeen 
participants were full-time employed, 12 participants were part-time, and seven participants were 
not employed. Thirty-two participants used disease-modifying therapies, and 26participants used 
symptom modifying therapies.  
 
2.5.2 Feasibility results 
 
 
a.) Process feasibility 
Recruitment rate and eligibility rate- Within our 5-week recruitment window, 561 persons opened 
the link to the online screening survey; of those, 135 potential participants completed the survey 
and were assessed for eligibility (recruitment rate: was 24%). Out of 135 potential participants, 
118 met the eligibility criteria described previously and consented to participation in the study 
(eligibility rate:87.40%). Of the 17 persons who were not eligible to participate in the study, seven 
had PDDS scores greater than four, nine had a relapse in the last 30 days, and one had an invalid 





study (n=12 GE, n=12 AE and n=12 control). We moved one participant from GE to the AE 
group after week two. This was done after mutual consideration of the research team and the 
participant. This participant was analysed with AE, and therefore the participants in the groups 
were n=11 for GE and n=13 for AE. We provided information about the two conditions 
(intervention and usual care) of the project on the screening page. After randomisation to group 
allocation, no participant (GE, AE, or Control) refused to participate in the study after 
communication via telephone calls (0% refusal rate). 
 
 
Table 5: Participants demographic statistics 
 Overall(n=36) Control(n=12) GE(n=11) AE(n=13) 
Mean age (SD) 43.28(13.3) 42.2(12.1) 41.7(12.5) 46.3(16.0) 






7:12:17 4:6:2 1:3:7 2:3:8 
Median PDDS 
score (Range) 
1.0 (3) 1.5 (3) 1.0 (3) 1.0 (3) 
MS Type (PR: 
RR) 
2:34 0:12 0:11 2:11 
Mean duration of 
MS(SD) 
7.5(6.5) 7.3(7.3) 6.5(6.3) 8.8(6.2) 
 
GE=General Exerciser, AE=Advanced Exerciser, NOTE: One-Way ANOVA for age (p=.64), duration 
of MS (p=.92) and PDDS (p=.82) show no significant differences between the groups at the baseline. 







b.) Resource feasibility 
Retention rate- The flow of the participants is presented in the CONSORT Figure (Figure.1). 
Thirty-one participants completed the month four questionnaire (post-intervention assessment) 
with an 86% retention rate, and thirty-one participants completed the month five questionnaire 
(early-follow up) with an 86% retention rate. Table 6 reflects the number of participants who 
completed the questionnaires at three-time points. One participant in the general exercise group 
continued the study for week 3, and the participant did not communicate with the research staff. 
Moreover, another participant from GE was moved to the advanced exercise group after week 
two after mutual consideration of the research team and the participant. One participant from AE 
did not communicate with the research team from week one, and another participant from AE 
had an adverse event (change in neurological symptoms) after six weeks, and then the participant 
dropped out of the study. Although the participant was agreed to continue the study on 
communication with the coach, she did not communicate further with the research staff. One 
more participant from AE had a severe adverse event (pulmonary embolism) in week 6. The 
participant continued the study, but we did not include it in the statistical analysis. This yields 27 
participants for analysis at five months, a retention rate of 75% (27/36). 
 
Reported barriers to participation- The main barriers to participation were, personal reasons (as 
participants did not respond to any communication with the research team) (n=1 GE, n=3 AE, 
n=3 Control), admitted to hospital for change in neurological symptoms (n=1 AE), admitted to 






Adherence to video coaching calls - The mean number of video coaching calls attended by each 
participant was 5.5 (±1.5) for GE and 5 (±1.6) for AE. The eleven participants in the GE group 
attended 61 out of 66 video coaching calls, 92% adherence rate. The thirteen participants of the 
AE group attended 61 out of 78 video coaching calls, 83.3% adherence rate. Ten participants of 
the GE group attended all six video coaching calls, and only one participant had participated in 
one out of six coaching calls. Eight participants of the AE group had attended all six calls, and 
two participants had attended five calls, two participants had attended three calls, one participant 
had attended one call. 
 
Outcome assessment reaction- During the baseline assessment questionnaire, 81% (29/36) of 
participants considered the questionnaire 'just right' in terms of a number of questions, and all 
participants (100%) were happy to answer all questions. The average time taken by participants 
to complete the questionnaire was 23 minutes. In the month four questionnaires, 68% (21/31) 
considered 'just right', 97% of participants were happy to answer all questions and the average 
time taken by participants to complete the questionnaire was 22 minutes. In the month five 
questionnaire, which contained the addition of the evaluation questions, 74% (23/31) considered 
'just right', all participants (100%) were happy to answer all questions and the average time taken 
by participants to complete the questionnaire was 32 minutes. 
 
Monetary cost: The equipment buying cost was AUD 192.00 for 24 pedometers (AUD 8.00 each) 





Table 6: List of participants who completed the questionnaires; (Resource feasibility) 
  GE AE Control Total 
Number of participants completed baseline 
questionnaire  
11* 13* 12 36 
 




























Number of participants completed Month 4 and 































Number of participants who did not complete 






























*One participant from GE shifted to AE and was analysed there. 
** One participant from AE completed all questionnaires but was not analysed because of experiencing 
an adverse event (pulmonary embolism) during the five month study period. 
  
The postage cost for 24 packages was AUD 360.00 (AUD 15.00 each). The total personnel time 
given by six staff members is 289 hours. For signifying the total personnel costs, the entire time 
given by personnel could be multiplied by the Australian MS specialist physios/OTs hourly rate 





by staff members. Therefore, the total study costs AUD 1512.00, excluding personnel costs, and 
the total per person cost for the study is AUD 2399.00, including personnel costs.  
 
Communication with participants: Initial communication with the participants via telephone calls 
for their confirmation to the study took 5-10 minutes for each participant (total 44 calls took avg 
8 minutes/call (352 minutes, 5.8 hours for all calls)). Then, the average time taken to complete 
introductory calls was 15-20 minutes per participant (a total of 36 calls took avg 12 minutes/call 
(432 minutes, 7.2 hours for all calls). All participants preferred to contact via video calls (Zoom, 
Facetime, Whatsapp or Skype) for intervention delivery. The coaches contacted participants 
according to participants preferred day and time, which was confirmed via text messages before 
each video call. Video coaching calls and note preparation time was 54 hrs in total for 11 
participants of GE and 36.5 hrs in total for 13 participants of AE. The mean duration of each 
video coaching call and note preparation for GE was 52.8 minutes (8.9), and for AE was 35.6 
minutes (1.6).  We also communicated with participants via text messages for compliance with 
the program. The postage time for the exercise equipment by the researchers and participants 
received the exercise equipment was nearly two months during COVID 19 emergency conditions. 
Only one participant had technical issues during video coaching calls which were managed by 
telephone calling (for audio) plus video call (for video) by the respective coach. 
 
Communication within research staff: There were 26 meetings held between six staff members. 
Two meetings (2 hours) for assessments preparation (on software training), nine meetings (9 





meetings (seven hours) for coaches’ training for delivering protocol and ongoing participants’ 
reviews, seven meetings (eight hours) for data analysis. 
 
c.) Management feasibility 
Ethics approval time: We received ethics approval from Murdoch University (Perth, WA) within 
six weeks of the application and the university granted ethics approval on 21/11/2019. We 
successfully registered the trial on 1/11/2019 with the Australian New Zealand Clinical Trials 
Registry ACTRN12619000228189. 
 
Staff skills: Six staff members were associated with the research, and Dr Paul Lorna (HCPC, 
Health Care Prof Council, UK registered Physiotherapist) was a consultant for the Giraffe 
healthcare physiotherapy portal. The three senior researchers were Dr Yvonne Learmonth, who 
is AHPRA (Australian Health Practitioner Regulation Agency) Accredited Physiotherapist and 
HCPC, Health Care Prof Council, UK registered Physiotherapist, Dr Timothy Fairchild, who is 
Accredited Exercise Physiologist and Dr Fleur van Rens, who is Exercise psychologist and the 
three junior researchers, Inderpreet Kaur (Physiotherapist, State Registered Paramedical council 
of Practitioners, M.P., India ) and Aiden-White Kiely (Accredited Exercise Physiologist), two 
were students of Master of Exercise Science (research) and Shavaughn Baynton is a student of 
Bachelor of Exercise Science and Physiology. The senior research staff provided 27 hours of 







Staff time for the study: The total time given to six staff members was 289 hours (including 8 
hours provided by MS advocacy groups for recruitment). The research material preparation time 
was 89 hours, including preparation for recruitment flyer, exercise manuals, e-newsletters, video 
coaching calls scripts and the Giraffe set-up for participants and questionnaires. The equipment 
choosing and purchasing time was one hour. The senior research Physiotherapist gave the 
recruitment time of eight hours, and MS advocacy groups (not included in research staff) also 
assisted in the recruitment. The randomisation time was four hours, staff meetings time was 27 
hours, initial calls and introductory calls to participants took 13 hours, video coaching calls and 
notes making time to GE was 54 hours, and for AE was 36.5 hours and 48 hours was data 
collection and analysis time.  
 
Equipment usage: We posted the pedometers and resistance exercise bands to the participants for 
the exercise training program; however, participants were also given full instructions on using 
mobile apps step-counting instead of pedometers. In the meantime, when participants received 
the pedometers and resistance exercise bands, participants either skipped the exercises for some 
time or used other resistance providing equipment. 
 
Processing time for data collection: The average duration for collecting data via online 
assessments (at baseline, month four and month five) from participants was 2-3 weeks. We 
contacted the participants three times, either via email or telephone calls or text messages, for 
completing the questionnaires. We entered and analysed the data exercise sessions from the 
Giraffe site to Microsoft Excel (107) for research use which took nearly 38 hours. We collected 






Data entry: We checked the data entered by the participants in the questionnaires and corrected 
the erroneous data by calling the respective participants. Only two participants had wrongly 
entered GLTEQ questions in the month four questionnaire.  
 
Software appropriateness: The use of Qualtrics software for outcome measurements had voided 
the analysis of data completeness.  Qualtrics provides a mobile-friendly version to save the 
answers and to continue them later, to attend all the questions and wherever necessary, skip logics 
were present. Besides, we could import the data to the Microsoft Excel (107) or SPSS files, which 
helped researchers to analyse the data quickly.  
   
 
d.) Scientific feasibility 
Safety: Six participants in the GE group and seven participants in the AE group had adverse 
events during the intervention, which was managed by either rest or consultation between the 
coach (and consultation with the supervising physiotherapist) and the participant. Further, we 
asked participants to independently report any adverse event via our month 4 and month 5 study 
questionnaire assessment. Gathering of information on adverse events in this manner was 
approved by the independent university ethical committee.  Any adverse events are illustrated in 
table 7. Two participants in the AE group had severe adverse events and were admitted to the 





embolism). The coaches of these participants had confirmed from the participants that these 
adverse events were not related to the study. Table 7 summarises the recorded safety data. 
 
Adherence and compliance for exercise program- Eight out of 11(73%) GE participants and five 
out of 13 (38%) AE participants adhered to ≥ 70% of total exercise prescribed sessions (combined 
aerobic and resistance). Seventy-three per cent of GE participants met our adherence criteria of 
attending ≥70% of total prescribed resistance exercise sessions, and 64% of GE participants met 
our adherence criteria of attending ≥70% of total prescribed aerobic exercise sessions. Sixty-two 
per cent of AE participants met our adherence criteria of attending ≥70% of total prescribed 
resistance exercise sessions, and 23% of AE participants met our adherence criteria of attending 
≥70% of total prescribed aerobic sessions. Fifty-six per cent of AE participants and 67% of GE 
participants participated in the prescribed balance exercises sessions. Fifty-one per cent of AE 
participants and 65% of GE participants attended the prescribed flexibility exercises. 
 
GE participants were compliant with 204 (58%) aerobic sessions out of 352 prescribed sessions; 
148 sessions were incomplete (or the participants did not enter data). GE participants were 
compliant with 186 (53%) resistance exercise sessions out of 352 total prescribed exercise 
sessions; 166 sessions were incomplete (or the participants did not enter data).  
 
Participants in the AE group were compliant with 395 (38%) aerobic sessions out of 1040 





Table 7: Safety data 
Details given by participants about their health status 









 M4 M5 M4 M5 M4 M5 
1. Participants visited or consulted with a health 
professional (in person or Telehealth)  
4 4 5 5 5 2 
2. Participants visited to the hospital 3 2 3 2 1 1 
3. Participants who had change (s) in MS 
symptoms 
3 4 3 2 4 2 
4. Participants who had change (s) in muscular 
or joint health 
4 2 4 3 3 1 
5. Participants who had fall(s)* 1 3 0 0 1 0 
6. Participants who had other health status 
changes not described above 
0 2 1 1 0 1 
Reported during video coaching calls or participants 
notified research staff 
      
1. Relapse 0 NA 0 NA NA NA 
2. Neuralgia or Psychological problems 1 NA 0 NA NA NA 
3. Knee injury 1 NA 1 NA NA NA 
4. Migraine  1 NA 1 NA NA NA 
5. Gluteal pain 1 NA 0 NA NA NA 
6. Reaction from medicine 1 NA 0 NA NA NA 
7. Sick 1 NA 1 NA NA NA 
8. High fatigue 0 NA 2 NA NA NA 
9. Admitted to hospital on a high dose of 
steroids 
0 NA 1 NA NA NA 
10. Flu 0 NA 1 NA NA NA 
11. Admitted to hospital for a clot in lungs 
(pulmonary embolism) 
0 NA 1 NA NA NA 
12. Infusion 0 NA 1 NA NA NA 
*(A fall is defined as an event which results in a person coming to rest inadvertently on the ground or 
floor or other lower level) 
 
 
AE participants were fully compliant with 204 (49%) resistance exercise sessions out of 416 total 





The mean duration of walking in GE increased from 26.8 minutes (±18.8) in week one to 63.2 
minutes (±18.9) in week 16. The mean duration of walking in AE was raised from 66 minutes 
(±29.9) in week one to 109 minutes (±52.2) in week 16. Figure 3 shows the weekly walking 
duration of the participants. The mean steps per aerobic session of GE were 4117.6 steps 
(±3078.4) in week one and increased to 6998.8 steps (±2756.4). The mean steps per aerobic 
session of AE were 10842.5 steps (±6702.4) in week one and increased to 13807.5 steps 
(±6661.3). Figure 4 depicts the weekly average walking steps of the participants. 
 
The mean number of resistance exercises were increased from 101 exercises (±47.6) to 237.2 
exercises (±185.1) in GE and 75.8 exercises (±71.4) to 197.5 exercises (±231.8) in AE from week 
one week 16, respectively. Figure 5 to figure 7 shows the weekly resistance, balance and 
flexibility exercises completed by the participants, respectively and figure 8 shows participants’ 
weekly RPE for resistance exercises. 
 
Intervention effect: There was medium time by group interaction on GLTEQ scores (np2=.06, 
F=.73). There was a small increase in current exercise participation of the GE participants 
(d=.38). Although the mean GLTEQ scores for AE were not increased post-intervention and at 
early follow-up, the GLTEQ scores were the highest for the AE compared to the control and GE 
group at all time points. Our study showed that the control group had moderate effect on the 







The acceptability of intervention to participants: As the participants were not profoundly familiar 
with the information in the e-newsletters, so they enjoyed the contents and provided positive 
feedback for the e-newsletters during video coaching calls. Regarding exercise sessions, some 
participants were familiar with the exercises and asked the coaches for some modifications. There 
were three levels of exercises, so it was flexible for the coaches to modify the exercises as per 
participants needs. Only one AE participant who had pulmonary embolism during the study was 
asked to stop the regular exercise sessions during the intervention. 
 
Participants’ evaluation of the intervention: Participants provided positive feedback for suitability 
of intervention to personal MS symptoms, personal fitness, and appropriateness of intervention 
in COVID 19 Pandemic and to deliver in the healthcare system (mean scores were >4 out of 5 
for the above statements, assessed during month five questionnaire).  Figure 9 reveals the 
participants’ evaluation of the intervention (0-not suitable/ do not recommend/ not appropriate/ 












Figure 3: Weekly Avg. Aerobic Exercise duration (time in minutes) completed by participants (GE 
and AE) Note: Video coaching calls were held in Week 3,5,7,10,12, and 15  
 
                              
                             


































































Figure 4: Weekly average total walking (Aerobic Exercise) steps completed by participants (GE and 
AE) 
 
                     
                       




















































Figure 5: Weekly Avg. Resistance Exercises completed by participants (GE and AE) 
   
                                 
























































































Figure 6: Weekly Avg. Balance Exercises completed by participants (GE and AE) 
 
                               





















































Figure 7: Weekly Average Flexibility Exercises completed by participants (GE and AE) 
 
                          























































Figure 8: Weekly Average Resistance Exercise RPE mentioned by participants (GE and AE) 
 
                





























































General Exerciser Mean 
(SD) 
Advanced Exerciser Mean 
(SD) 
Control Mean (SD) 






















































         
EG 23.2(9.6) 25.2(6.6) 25.8(9.8) 28.5(11.1) 32.8(11.5) 30.8(9.7) 24.5(11.0) 27.1(13.8) 23.4(11.9) 
EP 23.3(6.4) 25.4(4.7) 26.9(5.7) 30.0(4.8) 29.5(5.4) 31.1(5.2) 27.5(9.5) 30.3(7.8) 28.3(8.4) 
ESES 76.5(18.1) 69.7(17.7) 68.0(28.6) 92.2(8.7) 78.9(31.2) 77.7(34.0) 76.9(28.3) 66.7(38.1) 57.2(39.1) 
FSS 3.9(1.6) 4.3(1.0) 4.4(1.7) 3.6(1.1) 4.4(1.6) 4.0(1.0) 5.3(1.0) 5.5(.99) 5.7(.88) 
LMSQOL 10.5(4.2) 9.9(3.1) 9.2(3.0) 7.5(3.1) 9.9(3.1) 9.3(2.5) 12.8(4.8) 12.1(4.2) 10.7(5.3) 
MSWS 38.5(16.3) 34.0(12.8) 38.5(17.9) 37.3(22.7) 40.4(27.3) 38.9(24.1) 45.1(22.2) 47.7(20.8) 45.9(23.5) 
ABC 8.3(1.8) 8.4(1.6) 8.5(1.2) 8.7(1.4) 8.1(2.1) 8.2(1.9) 7.8(2.2) 7.8(2.1) 7.6(2.0) 
HADSA 7.9(3.6) 7.0(2.9) 7.5(3.3) 4.6(3.7) 5.4(2.5) 6.1(3.2) 7.9(5.0) 8.7(5.7) 7.0(5.5) 
HADSD 5.8(3.4) 5.4(3.4) 7.0(3.8) 3.3(2.8) 4.1(2.6) 4.4(2.5) 7.1(4.3) 8.3(5.0) 6.4(4.4) 
PNSES_C 4.5(.86) 4.5(.43) 4.4(.86) 4.8(1.0) 4.5(1.4) 4.6(1.1) 3.9(1.2) 3.2(1.5) 3.1(1.4) 
PNSES_R 3.3(1.8) 3.5(1.5) 3.8(1.3) 4.8(1.7) 4.3(1.4) 4.5(1.7) 4.2(1.5) 3.9(1.4) 3.9(1.7) 
PNSES_A 4.2(.62) 4.6(.44) 4.6(.54) 4.6(.38) 4.3(.97) 4.6(.63) 4.3(.87) 4.0(1.0) 4.0(.9) 
 
GLTEQ- Godin leisure-time questionnaire; EG- Exercise goal setting and planning scale (goal 
component); EP- Exercise goal setting and planning scale (planning component); ESES- Exercise self-
efficacy scale; FSS- Fatigue severity scale; LMSQOL- Leeds MS quality of life scale; MSWS- Multiple 
sclerosis walking scale; ABC scale- Activities-specific balance confidence scale; HADSA- Hospital 
anxiety depression scale- anxiety component; HADSD- Hospital anxiety depression scale- depression 











































































         
EG 0.27 0.20 -0.1 .06 .69 .59 2 4.3 2.6 
EP 0.56 0.23 0.08 .08 .98 .42 2.1 -0.5 2.8 
ESES -0.47 -1.67 -0.69 .02 .29 .88 -6.8 -13.3 -10.2 
FSS 0.31 0.36 0.4 .04 .46 .76 0.4 0.8 0.2 
LMSQOL -0.30 0.58 -0.44 .19 2.8 .04 -0.6 2.4 -0.7 
MSWS 0 0.07 0.04 .09 1.3 .29 -4.5 3.1 2.6 
ABC 0.11 -0.36 -0.09 .09 1.3 .27 0.1 -0.6 0 
HADSA -0.11 0.40 -0.18 .09 1.1 .35 -0.9 0.8 0.8 
HADSD 0.35 0.39 -0.16 .12 1.7 .17 -0.4 0.8 1.2 
          
PNSES_C -0.11 -0.2 -0.67 .09 1.2 .34 0 -0.3 -0.7 
PNSES_R 0.27 -0.18 -0.2 .05 .68 .61 0.2 -0.5 -0.3 
PNSES_A 0.64 0 -0.34 .12 1.7 .17 0.4 -0.3 -0.3 
GLTEQ- Godin leisure-time questionnaire; EG- Exercise goal setting and planning scale (goal 
component); EP- Exercise goal setting and planning scale (planning component); ESES- Exercise self-
efficacy scale; FSS- Fatigue severity scale; LMSQOL- Leeds MS quality of life scale; MSWS- Multiple 
sclerosis walking scale; ABC scale- Activities-specific balance confidence scale; HADSA- Hospital 
anxiety depression scale- anxiety component; HADSD- Hospital anxiety depression scale- depression 








Figure 9: Intervention evaluation by the participants (GE and AE) 
 
                             


























Suitability, recommendation and appropriateness of 
































Our study monitored the four aspects of feasibility (process, resource, management and scientific) 
for the remotely delivered exercise program embedded with behaviour interventions to persons 
with MS. Telehealth programs (75) are vital to promote and deliver healthcare services to persons 
living in remote areas or unable to benefit from in-person healthcare services. During the COVID-
19 period, when telehealth services were of great significance, our study helped to keep active 
participants active and increase activity in less active participants by engaging them in exercises. 
Telehealth programs are of great importance for future studies and clinical practice. The findings 
of our study showed that it is feasible to deliver a remote, home-based, online exercise program 
based on the latest exercise guidelines and implemented with behaviour interventions to persons 
with mild to moderate MS. 
 
The process feasibility outcomes show a 24% recruitment rate, which lies between the range of 
11%-52% of previous studies (40,48,53,77). Our study's recruitment determines the interest of 
persons with MS to be involved in research related to exercise and that persons with MS are 
searching for such novel research. The recruitment for our study was done by only two methods; 
via a university database which included the participants who were involved in previous related 
research and through social media pages of our third party collaborators (MS Australia, MS 
Research Australia, and others mentioned in recruitment) for only five weeks, and 135 persons 
completed the online screening. The unexpected large number of interested persons within a short 
duration of recruitment indicates that the recruitment process was effective and could be used for 





recruitment like postal services, email, and telephone rather than social media recruitment which 
might result in a higher recruitment rate. We acknowledge that using postal services for the 
recruitment could delay recruitment; however, recruiting via neurology clinics and rehabilitation 
centres could have provided more potential participants for the study. To improve future 
recruitment rates, studies could use flyers at different neurology clinics to recruit more potential 
participants.  
 
Nevertheless, our study’s eligibility rate of 87.4% is less than the previous study (40), yet 
comparable to other studies (48,53,108,109). Our study's eligibility rate indicates that the 
inclusion criteria for the study were appropriate to determine the target population. The previous 
study by Learmonth et al. used detailed information about the eligibility criteria while recruiting 
and required a PDDS score of ≤3.0. Persons with MS already engaged in the exercises were not 
recruited, which might have resulted in higher eligibility rates than our study. However, our 
eligibility criteria included a broader inclusion criterion of PDDS ≤4.0 and inclusion of persons 
with MS who were already active. This may have lowered the eligibility rate, but it is comparable 
with similar studies (48,53,108,109), which demonstrates our eligibility criteria is optimal and 
can be used for larger future trials. Thus, outcomes of process feasibility for our study show that 
it was acceptable to the target population.  
 
Regarding resource feasibility, the retention rate of 75% lies within the range of previous studies 
(40,53,58,79,108). The retention rate for GE (10/11=90%) was higher than AE (8/13=61%), 
which indicated the study was more appropriate to persons with mild to moderate MS who were 





because they were already engaged in exercises, and might be they were more fatigued with their 
scheduled exercises along with our program, or they could have found our exercise program as 
less beneficial for them.  Our study’s retention rate determines the preliminary effectiveness of 
the research protocol in improving exercise adherence of the persons with MS. Clinically, the 
retention rate can be increased by a more effective conversation between clinical staff and patients 
and by providing more intensified and flexible exercise programs to the patients.  
 
During coaching video calls, the note preparation time before video coaching calls was not 
included in the methodology, and coaches believed participants were competent and spent some 
time preparing notes before each video coaching call. The adherence rate for video coaching calls 
was 92% for GE and 83% for AE, which is higher than previous studies (40,53). We provided 
more time to the participants during video coaching calls than previous studies (40,53) and tried 
to establish better health professional and client relationships. Our study’s higher adherence rate 
to the behavioural coaching calls indicates the appropriate use and display of SCT principles in 
the e-newsletters and its discussion with the participants. We have provided future large trials 
with more extensive use of SCT principles for changing behaviour towards exercise.  
 
Our adherence rate to the exercise program for GE is comparable to the previous study by 
Kinnett-Hopkins and Motl in 2018 (53), while our results were in contrast to the original GEMS 
study (40). In our study, we used three different levels of progression arms (red, black, and white), 
similar to GEMS study (orange, blue, and white) however, we used online videos for resistance 
exercises, rather than posting DVDs of exercise videos, as was the case in the original GEMS 





there were drops in the progression of exercises in the AE group; which can be seen in figures 3-
5. Further, participants appreciated readily available online exercise videos on Giraffe healthcare 
portal, which helped participants to continue their programs with either a low or high exercise 
difficulty. Our study showed that in clinical practices, for remote delivery of exercise programs, 
it is feasible to use online healthcare portals which provide a broad range of exercise videos and 
has individualised levels of difficulty. Future trials can use a similar exercise protocol for remote 
delivery of exercise programs in persons with MS.  
 
Our exercise program had additional balance and flexibility exercises, which were not present in 
the GEMS study (40). The addition of balance and flexibility exercises in week five of the 
program assisted the participants to remain involved in the program. In addition, participants 
perceived the balance exercises helpful and flexibility exercises as relaxing; reported during 
video coaching calls and in their comments for exercises on the Giraffe portal. We provided a 
platform for using an exercise program with updated guidelines by Kim et al. (61) via our 
feasibility study, and future large trials can determine the use of these guidelines for clinical 
practices.  
 
We delivered most of the study materials (manuals, e-newsletters, online videos, and online 
diaries) through the internet and used postal services only for exercise equipment delivery. We 
determined a lower study cost to ensure affordability to conduct future large-scale trials and 
encourage use in clinical practices. It is also timesaving to deliver study material online instead 
of via postal services. However, we understand that the online delivery of material is limited to 





technologically inclined. When delivering exercise equipment to participants, we faced an 
extended postal time, which may be associated with restricted postal services during the COVID-
19 period. However, these delays should not be present in future trails when restrictions have 
been removed. Moreover, we described the communication with the participants and within the 
six-core staff members, which will help the future large trials to organise the personnel time and 
costs.  
 
Our study's management feasibility outcomes showed that personnel time, data processing time, 
and equipment usage was preliminary effective in maintaining the participants' engagement in 
the study for an extended duration of five months. The total personnel time (289 hrs) was higher 
than the previous studies (40,53). Most of the time is associated with participant communication 
and data entry from online diaries for research use. Future research could use similar software 
applications, which may be expensive to maintain for a long duration to complete the self-
reported exercise sessions for saving data entry time. However, participant communication time 
should be appropriate to ensure participant assurance and involvement in the protocol.  
 
Data collection time from online questionnaires was 2-3 weeks, comparable to previous studies 
(40,53) and importantly, the online assessments saved postage time for data collection. We used 
Qualtrics software (84) for online assessments, and distributed them to participants via an online 
link. We established the appropriateness of using the software for future trials. We checked the 
online outcome assessments from Qualtrics and found that two participants had incorrectly 





inputs. To that end, we have deemed it feasible to use Qualtrics for future outcome assessments, 
however it is limited to individuals who are able to confidently use online technology.  
 
For scientific feasibility outcomes, we assessed the safety and scientific outcomes of the remote 
delivery of the protocol. We provided information about participants’ adverse events during the 
intervention and at the time of outcome assessments. Despite a few mild adverse events, 
participants continued involvement with the study. One participant discontinued the study after a 
severe adverse event, and another participant with a severe adverse event (pulmonary embolism) 
discontinued the exercise program but completed all assessments; however we did not involve 
the participant in the analysis. The safety data of our study is consistent with previous studies’ 
data plan (40,53,57). 
 
With regard to scientific outcomes, there was a small intervention effect on the primary outcome 
of exercise participation as measured by GLTEQ on GE which is consistent with previous studies 
(40,53), while there was no effect on AE. The primary scientific outcome of increased exercise 
participation showed that our study protocol was more appropriate  for individuals identified as 
being non exercisers (not engaging in 30 or more minutes of moderate-intensity aerobic exercise 
2+ days/week and 30 or more minutes of resistance training on 2+ days/week) rather than 
individuals who are already engaging in an exercise program. There was an increase in the goals 
and planning scale scores for both GE and AE, indicating that our protocol was successful in 
changing behaviour towards exercise goals and planning of persons with MS. Indeed, our study 
is the first study to demonstrate increasing exercise goal and planning for the persons with MS 





Further, previous studies have shown that exercises are important for increasing health-related 
quality of life (19,56,58,110) however, more research is needed to deduce the effect of exercise 
programs to improve quality of life. To that end, our study showed that there was a moderate 
increase in quality of life as measured by LMSQOL in GE but no increase in AE. It is interesting 
to note that the control group demonstrated a moderate increase in exercise participation as 
measured by GLTEQ. This might be because the control group included persons with MS who 
were already engaged in exercise. It is also likely that persons with MS who enrol into an 
exercise-based program have the intention of increasing their exercise levels and will therefore 
engage in more exercise whether they are allocated to the intervention group or control group. 
To our knowledge, there are no previous studies who observed the phenomenon in control group, 
rather the studies deduced the information regarding intervention group (24,40,53). Further, to 
emphasise, the study by McEwan et al. 2020 demonstrated that there is decrease in exercise 
behaviour of persons with MS after the intervention is over whether investigations on controlled 
or intervention group (111). Overall, the study’s scientific outcomes provide support for the 
conduct of a large future trial to increase the primary outcome of exercise participation and 
secondary outcomes of goal setting and planning and quality of life, especially in those with the 
lowest level of current exercise participation levels.  
 
Furthermore, we provided participant’s evaluation for our intervention program which indicates 
that our study was acceptable to the target population and showed satisfaction of  participants to 
our intervention which is similar to original GEMS study (40). However, the study by Ryan et al. 





interviews for acceptance of their program, we did not ask feedback of intervention from control 
participants.   
 
Despite our study's feasibility, safety, and preliminary effectiveness  in remotely delivering a 
home-based exercise program with behaviour interventions, we acknowledge that our study had 
some limitations. The broad age-range (18 years and above) in our inclusion criteria might not 
be compatible with the use of technology and limits the involvement of only a part of the target 
population to our study. However, participants completed all screening and pre-participation 
questionnaires online which means most would have a reasonable grasp of technology prior to 
enrolment. The online delivery of exercise videos via Giraffe healthcare portal required laptop or 
tablet which might not be affordable for all participants, and one of our participants had to delay 
study involvement due to the requirement for buying a tablet to initiate the program. We 
overcame the situation by providing the pdf version of the exercise program to the participant. 
The other limitation was that we found that the participants who were already engaged in 
exercises less adhered to our program and a more intensified protocol might be useful. Moreover, 
the exercise program was designed for persons with mild-to-moderate MS which cannot be 
generalised to individuals with more advanced stages of the disease. We had a student to 
implement a complex intervention and provide behaviour change, which is not an undergraduate 
skill and is a limitation to our study. This limitation can be overcome by introducing a behaviour 
coach to provide behaviour change techniques to the participants.   Finally, despite the multiple 
contacts and reporting, our exercise program is home-based, so it has limitations in monitoring 








We concluded that it is feasible, safe, and efficacious to deliver a remote exercise program with 
updated exercise guidelines (61) and embedded with behaviour intervention to persons with mild-
to-moderate MS. Future definitive trials could examine that the persons with mild-to-moderate  
MS who are not engaged in exercises according to recommended guidelines (10) could increase 
their exercise participation via telehealth programs. Our study directs future research in that it 
will improve the understanding of the feasibility protocols for the persons with mild-moderate 
MS who are already engaged in exercise according to original guidelines (10) to validate updated 
guidelines (61).  
 
2.8 LIST OF ABBREVIATIONS 
 
MS- Multiple Sclerosis 
SCT- Social Cognitive Theory 
GE- General Exercisers 
AE- Advanced Exercisers 
GLTEQ- Godin leisure-time questionnaire 
 EG- Exercise goal setting and planning scale (goal component) 
EP- Exercise goal setting and planning scale (planning component) 
 ESES- Exercise self-efficacy scale; FSS- Fatigue severity scale 
 LMSQOL- Leeds MS quality of life scale; MSWS- Multiple sclerosis walking scale 
 ABC scale- Activities-specific balance confidence scale 
 HADSA- Hospital anxiety depression scale- anxiety component 
 HADSD- Hospital anxiety depression scale- depression component 






CHAPTER 3- PRACTICAL IMPLICATIONS AND FUTURE RESEARCH 
  
3.1 PRACTICAL IMPLICATIONS 
 
Our study was a feasibility study of remotely delivered, online home-based exercise program 
embedded with behaviour interventions, primarily to increase the exercise participation for the 
persons with mild-to-moderate MS. In line with the present study, clinically, the healthcare 
professionals can use remotely supervised online exercise programs to engage persons with mild 
to moderate MS in exercises. Additionally, healthcare professionals should use behavioural 
change principles while working with patients to adhere to the exercises. Our study helps engage 
persons with MS in exercise during emergency conditions like COVID-19. Moreover, following 
our study, future definitive trials could examine the efficacy of these updated guidelines for 
exercise for persons with mild to moderate MS. In conclusion, the future definitive randomised 
controlled trial could provide clinical approaches to implement the online delivery of exercise 
programs to persons with MS.  
 
3.2 FUTURE RESEARCH 
 
Our study was feasible, preliminary efficacious and safe for remotely delivering the home-based 
exercise program with behaviour interventions. The study determines future definitive trials for 
increasing exercise participation and quality of life of persons with mild-to-moderate MS who 





exercise participation and long-term exercise adherence of persons with mild-to-moderate MS 
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                                                                              2.B) INFORMATION PAGE 
Delivering a remote exercise program embedded with behaviour interventions to 




Welcome potential participant!    
You are invited to participate in a research study; Delivering a remote exercise program embedded 
with behaviour interventions to persons with multiple sclerosis (MS)" that focuses on community 
exercise for people with Multiple Sclerosis. The study will be run by researchers from Murdoch 
University, WA, Australia. 
  
What are the reasons for the study? 
Engaging in physical activity is beneficial to the wellbeing of people with MS. The aim of the study is 
to assess the feasibility of a study designed to involve people with MS in an exercise program. This 
study is a feasibility study, meaning that we will focus on the process of the study in terms of rates of 
recruitment, adherence, and retention of participants. Another focus point will be resources required, 
such as time, cost and equipment. We will further focus on the outcomes of people who participate in 







If you decide to take part in this research study, it is important that you have a full understanding of the 
purposes of the study and the tasks that you may be asked to complete during your participation. Please 
understand that you can raise any questions or concerns that you have, and that they have been 
answered to your utmost satisfaction before you consent to participate. 
  
What the study involves: 
If you decide to take part in the study, you will be asked to complete the following tasks: 
Complete an online questionnaire before the commencement of your intervention that should take no 
longer than 20 minutes. The questionnaire will ask you questions about your MS, any MS medications 
you are taking and about your health habits in relation to your current activity levels  You will then be 
randomly selected to take part in one of two conditions as follows: 
  
If you are selected for Condition 1 – Exercise condition; 
You will be required to complete the exercise individually at home or in your own community, and the 
exercise will involve sessions of aerobic walking and sessions of resistance training each week for up 
to 5 months, the number of sessions will be based on the current physical activity guidelines for MS 
and based on your previous history of exercise. You will receive emails and telephone/video calls from 
our team of physiotherapists and clinical exercise physiology students. You will provide feedback on 
your progress with the intervention at different stages of the study. After month 4, and month 5 you 
will be asked to complete the questionnaire on MS and health habits. 
  
If you are selected for Condition 2 – Usual care condition; 
You do not need to change your lifestyle behaviours. You will be asked to complete the questionnaire 






Voluntary Participation and Withdrawal for the research study: 
It is important that you understand that your participation in this study is completely voluntary and that 
you may withdraw at any stage without discrimination or prejudice. All information provided by you is 
treated will complete confidentiality and no names or identifying factors are used in any publications or 
presentations that arise from this research study. If you withdraw from the study within 2 weeks of 
starting, then all the information that you have provided will be deleted. We reserve the right to 
maintain outcome measurement data collected from you should you remain in the study after 2 weeks 
of starting the study. 
  
Privacy: 
Your privacy is of utmost importance, and whether you elect to participate in the study or not will be 
kept completely confidential. 
  
Benefits of the study: 
There is no guarantee that you will personally benefit by participating in the study, the information 
gained from participation may help others with MS in the future, as well as researchers and clinicians. 
Please note that while there is strong research indicating the benefit of exercise in persons with MS, the 
benefits are not the same for everyone and exercise is not a solution to your medical situation and may 
not lead to improvement. 
  





There are no specific risks involved with participation in this research study. However, if you have any 




Main Study contact e-mail: mshealthstudy@murdoch.edu.au 
  
Supervising researcher: 
Yvonne Learmonth, e-mail: yvonne.learmonth@murdoch.edu.au 
  
Once we have analysed the information relating to the study, we will post a summary of the findings on 
the website of the Discipline of Exercise Science, College of Science, Health, Engineering and 
Education, Murdoch University. You can expect to receive this feedback in 2021.  
 
If you are willing to consent your participation in the research study, please complete the Consent 
Form. 



































This study has been approved by the Murdoch University Human Research Ethics Committee 
(Approval 2019/021). If you have any  reservation  or complaint about the ethical conduct of this 
research, and wish to talk with an independent person, you may contact Murdoch University’s 
Research Ethics Office (Tel. (+61 8) 9360 6677) or e-mail ethics@murdoch.edu.au). Any issues 













Prior to participation in this research project, we require your consent. Please indicate below 
whether you consent to the following:  
  
1.       I voluntarily agree to take part in the study. 
2.       I have read through the information document in full and have a complete understanding of what 
is required of me for the duration of this study. 
3.       I understand that at times I will be asked to: 
a.       Complete questionnaires that can take up to 20 minutes. 
b.       Communicate over the phone or E-mail with researchers about my progress in the study. 
4.       I realise that as part of the study I may be required to complete a standardised exercise program 
over the duration of the study. 
5.       I understand that this study includes a control group who will not receive the exercise program, 
and I agree to continue in the study regardless of whether I am randomly allocated to the exercise 
program or control group. 
6.       I agree that the researchers have answered all my questions relating to the study and its goals, as 
well as explained the possible issues that may arise as a result of my participation in this study. 
7.       I understand that I am free to withdraw at any time from the study without providing reason for 
my actions. 





9.       I have a full understanding that my name and identity will be stored separately from the data, and 
that this information will only be accessible to researchers related to the study. Any data provided by 
me will be analysed anonymously using unidentifiable codes. 
10.   I understand that all information provided by me will be treated as confidential and will not be 
released by the researchers to a third party unless required to do so by law. 
11.   I agree to my de-identified data being used in future research projects. 
 
• Yes, I consent to begin the study. (1) 











































Thank you for your interest in participating in our study. We would now like to gather some 
basic contact information from you, so that we know how to get in touch with you for this study.  
1. What is your name? 
2. What is your contact phone number? 
3. What is your contact email? 
4. Do you consent to being contacted by Murdoch University to be invited into future relevant 
studies in this area? Yes (1) No (2) 
 
Now, we would like to gather some information on your eligibility to take part, please answer 
the following questions and we will let you know.  
1. Are you over 18 years of age? Yes (1) No (2)  
2. Do you have a diagnosis of multiple sclerosis? Yes (1) No (2)  
3. Have you had a relapse of your MS symptoms in the past 30 days? Yes (1) No (2)  
4. Do you currently participate in 30 or more minutes of moderate intensity aerobic exercise 
on 2 or more days a week? Yes (1) No (2) 
 
5. Do you currently participate in 30 or more minutes of resistance training on 2 or more days 






PDDS (PDDS Patient-Determined Disease Steps) 
The following question is about the level of disability you experience and your ability to walk. Please 
read the choices listed below and choose the one that best describes your own situation. This scale 
focuses mainly on how would you describe your ability to walk. Not everyone will find a description 
that reflects their condition exactly, but please mark one category that describes your situation the 
closest.   
• 0 Normal: I may have some mild symptoms, mostly sensory due to MS but they do not limit 
my activity. If I do have an attack, I return to normal when the attack has passed.  (1)  
• 1 Mild Disability: I have some noticeable symptoms from my MS but they are minor and have 
only a small effect on my lifestyle.  (2)  
• 2 Moderate Disability: I don't have any limitations in my walking ability. However, I do have 
significant problems due to MS that limit daily activities in other ways.  (3)  
• 3 Gait Disability: MS does interfere with my activities, especially my walking. I can work a 
full day, but athletic or physically demanding activities are more difficult than they used to be. I 
usually don't need a cane or other assistance to walk, but I might need some assistance during 
an attack.  (4)  
• 4 Early Cane: I use a cane or a single crutch or some other form of support (such as touching a 
wall or leaning on someone's arm) for walking all the time or part of the time, especially when 





cane or crutch. I always need some assistance (cane or crutch) if I want to walk as far as 3 
blocks (approximately 300m).  (5)  
• 5 Late Cane: To be able to walk 25 feet (approximately 8 metres), I have to have a cane, crutch 
or someone to hold onto. I can get around the house or other buildings by holding onto furniture  
• touching the walls for support. I may use a scooter or wheelchair if I want to go greater 
distances.  (6)  
• 6 Bilateral Support: To be able to walk as far as 25 feet I must have 2 canes or crutches or a 
walker. I may use a scooter or wheelchair for longer distances.  (7)  
• 7 Wheelchair / Scooter: My main form of mobility is a wheelchair. I may be able to stand 
and/or take one or two steps, but I can't walk 25 feet, even with crutches or a walker.  (8)  
• 8 Bedridden: Unable to sit in a wheelchair for more than one hour.  (9)  
 
 For eligible participants 
You have met the eligibility criteria to participate in our study. We would now like to collect some 
more demographic information about you. Please complete the following questions.   
1. What is the best time of day to contact you over the phone?    For example, morning, afternoon, 
evening, specify a day of the week, and time. 
2. What is your postcode? 
3. What is your date of birth? 





Thank you for completing this questionnaire. A member of the research team will get in touch with you 
concerning your participation in this study. In the meantime, if you have any further questions about 
this project, please do not hesitate to contact us by emailing mshealthstudy@murdoch.edu.au. 
For ineligible participants 
Thank you for your interest in this study. At this time, the information you have provided suggests that 
this study may not be suitable for you. Murdoch University researchers are continuing to conduct 
research studies in the area of physical activity and exercise, as you have already shown interest in our 
research studies we may get in touch (if you have indicated that you are interested in being contacted 
by us for future research). 
















APPENDIX 3- DEMOGRAPHIC INFORMATION, MEDICATIONS AND 
OUTCOME MEASURES 
 
1. Please provide your User ID (as provided to you by the research team): 
2. How are you employed?   Full-time employed (1) Part-time employed (2) Not employed (3)  
3. When were you diagnosed with MS (i.e., year)? 
4. What type of MS do you have? Relapsing remitting (1) Primary progressive (2) Secondary 
progressive (3)  
5. Are you currently taking any Disease Modifying Therapy (DMT) medications? Yes (1) No 
(2)  
6. Which DMT medication are you taking?  
• Avonex (interferon beta-1a) 
• Betaferon (interferon beta-1b) 
• Botox (botulinum toxin type A) 
• Copaxone (glatiramer acetate) 
• Fampyra (fampridine) 
• Gilenya (fingolimod) 
• Lemtrada (alemtuzumab) 
• Ocrevus (ocrelizumab) 
• MAVENCLAD (Cladribine) 
• Plegridy (peginterferon beta-1a) 
• Rebif (interferon beta-1a) 





• Tecfidera (dimethyl fumarate) 
• Tysabri (natalizumab) 
• Other (please provide information)________________________ 
7. Are you currently taking symptomatic therapies? Yes (1) No (2) 
8. Which symptomatic therapies are you taking? 
• Botox – for the treatment of urinary incontinence 
• Fampyra - to improve walking 
• Sativex – to alleviate muscle stiffness (spasticity) 
• Baclofen – for muscle control and to alleviate spasticity 
• Naltrexone – to address fatigue and depression 
• Ditropan, Betmiga – for bladder dysfunction 
• Other (please provide information)________________________ 
9. Have you ever been advised by a healthcare professional to participate in exercise?  Yes 
(1) No (2) 
10.  Which healthcare professional(s) advised you to participate in exercise?  
• Neurologist 
• MS nurse 
• Physiotherapist 
• Occupational therapist 
• Exercise physiologist  







The following questionnaires were asked at all time points  
Questionnaires 
Exercise Goal Setting and Planning Questionnaire 
Exercise Goals 
The following questions refer to how you set exercise goals and plan exercise activities. Please indicate the extent to 
which each of the statements below describes you: 
 
 
Does not describe Describes completely 
 
1. I often set exercise goals .......................................................................................... 1 2 3 4 5 
2.I usually have more than one major exercise goal .................................................... 1 2 3 4 5 
3. I usually set dates for achieving my exercise goals ................................................. 1 2 3 4 5 
4. My exercise goals help to increase my motivation for doing exercise .................... 1 2 3 4 5 
5. I tend to break more difficult exercise goals down into a series of smaller goals. 1 2 3 4 5 
6. I usually keep track of my progress in meeting my goals ......................................... 1 2 3 4 5 
7. I have developed a series of steps for reaching my exercise goals .......................... 1 2 3 4 5 
8. I usually achieve the exercise goals I set for myself ................................................. 1 2 3 4 5 
9. If I do not reach an exercise goal, I analyze what went wrong ................................. 1 2 3 4 5 
















The following questions refer to how you fit exercise into your lifestyle. Please indicate the extent to which each of the 
statements below describes you: 
 
Does not describe Describes completely 
 
1. I never seem to have enough time to exercise ........................................................ 1 2 3 4 5 
2. Exercise is generally not a high priority when I plan my schedule ........................ 1 2 3 4 5 
3. Finding time for exercise is difficult for me ........................................................... 1 2 3 4 5 
4. I schedule all events in my life around my exercise routine ................................... 1 2 3 4 5 
5. I schedule my exercise at specific times each week ............................................... 1 2 3 4 5 
6. I plan my weekly exercise schedule ........................................................................ 1 2 3 4 5 
7. When I am very busy, I don’t do much exercise .................................................... 1 2 3 4 5 
8. Everything is scheduled around my exercise routine—both classes and work.  . 1 2 3 4 5 
9. I try to exercise at the same time and same day each week to keep     
a routine going. 1 2 3 4 5 
10. I write my planned activity sessions in an appointment book or calendar .............. 1 2 3 4 5 
 
Exercise Self-efficacy questionnaire 
The items listed below are designed to assess your beliefs in your ability to accumulate 30 or more 
minutes of moderate to vigorous physical activity on most days of the week in the upcoming 
months. Moderate activities are similar to a brisk walk and vigorous activities are similar to what it 
feels like to run. For this activity, please only consider physical activities that occur for 10 minutes 
at a time. Using the scales listed below please indicate how confident you are that you will be able 
to be physically active in the future. 
For example, if you have complete confidence that you could accumulate 30 or more minutes of 
moderate to vigorous physical activity on most days of the week in the next month, you would circle 
100%.  However, if you had no confidence at all that you could participate in physical activity for 
the next month without quitting, you would circle 0%. 
Please remember to answer honestly and accurately.  There are no right or wrong answers. 
0% 10% 20% 30% 40%  50% 60% 70% 80% 90% 100% 
NOT AT ALL MODERATELY HIGHLY 
CONFIDENT CONFIDENT CONFIDENT 
 
1. I am able to participate in physical activity most days of the week at moderate intensity, for 30+ 
minutes 





0% 10% 20% 30% 40%  50% 60% 70% 80% 90% 100% 
2. I am able to participate in physical activity most days of the week at moderate intensity, for 30+ 
minutes without quitting for the NEXT TWO MONTHS. 
0% 10% 20% 30% 40%  50% 60% 70% 80% 90% 100% 
3. I am able to participate in physical activity most days of the week at moderate intensity, for 30+ 
minutes without quitting for the NEXT THREE MONTHS. 
0% 10% 20% 30% 40%  50% 60% 70% 80% 90% 100% 
4. I am able to participate in physical activity most days of the week at moderate intensity, for 30+ 
minutes without quitting for the NEXT FOUR MONTHS. 
0% 10% 20% 30% 40%  50% 60% 70% 80% 90% 100% 
5. I am able to participate in physical activity most days of the week at moderate intensity, for 30+ 
minutes without quitting for the NEXT FIVE MONTHS. 
0% 10% 20% 30% 40%  50% 60% 70% 80% 90% 100% 
6. I am able to participate in physical activity most days of the week at moderate intensity, for 30+ 
minutes without quitting for the NEXT SIX MONTHS. 
0% 10% 20% 30% 40%  50% 60% 70% 80% 90% 100% 
 
 
The Fatigue Severity Scale 
The following statements ask about your experience with MS-related fatigue. Please indicate the extent 
to which you agree with each statement listed below by using the scale which follows.  Select the 
response that most closely matches your own, remembering that there are no right or wrong answers. 
1 = strongly disagree  
2 = disagree 
3 = slightly disagree 
4 = neither agree nor disagree  
5 = slightly agree 
6 = agree 
7 = strongly agree 
During the past 4-weeks, I have found that: SCORE 
1. My motivation is lower when I am fatigued. 1 2 3 4 5 6 7 
2. Exercise brings on my fatigue. 1 2 3 4 5 6 7 














 Godin Leisure Time Exercise Questionnaire 
Considering a 7-Day period (a week), how many times on the average do you do the following kinds 
of exercise for more than 15 minutes during your free time (write on each line the appropriate 
number). 
                                                                                                        Times per week 
a.) Strenuous exercise (Heart beats rapidly)                          _______________ 
(i.e. running, jogging, hockey, football soccer, squash, basketball, cross country 
skiing, judo, roller skating, vigorous swimming, vigorous long distance 
bicycling) 
b.) Moderate exercise (Not Exhausting)                                 _______________ 
(i.e. fast walking, baseball, tennis, easy bicycling, volleyball, badminton, 
alpine skiing, easy swimming, popular and folk dancing) 
c.) Mild exercise (Minimal effort)                                             _______________ 
 (i.e. yoga, archery, fishing from river bank, bowling, horseshoes, golf, snow-mobiling, easy walking) 
 
 
Considering a 7-day period (a week), during your leisure-time, how often do you engage in any 






Hospital Anxiety and Depression Scale 
For the following 14 items, please select the choice that best describes how you have felt over the past 
4-weeks. 
4. Fatigue interferes with my physical functioning. 1 2 3 4 5 6 7 
5. Fatigue causes frequent problems for me. 1 2 3 4 5 6 7 
6. My fatigue prevents sustained physical functioning. 1 2 3 4 5 6 7 

























































 Most of 
the time 





Not at all 
1. I feel tense or “wound up.”     
2. I still enjoy the things I used to enjoy.     
3. I get a sort of frightened feeling as 
if something awful is about to 
happen. 
    
4. I can laugh and see the funny 
 
side of things 
    
5. Worrying thoughts go through 
my mind. 
    
6. I feel cheerful.     
7. I can sit at ease and feel relaxed.     
8. I feel as if I am slowed down.     
9. I get a sort of frightened feeling 
 
like “butterflies” in the stomach. 
    
10. I have lost interest in my 
 
appearance. 
    
11. I feel restless as if I have to be on 
the move. 
    
12. I look forward with enjoyment to 
 
things. 
    
13. I get sudden feelings of panic. 
 
    
14. I can enjoy a good book or radio or 
TV program. 






Leeds MS QOL Scale 
 
Please indicate the extent to which you agree with each statement listed below by using scale which 
follows. Select the response that most closely matches your own, remembering that there no right or wrong 
answers. 
1= Not at all 
2= A little  
3=Quite a lot 
4=Very much 
1. _____________ My health has affected my relationships with my family. 
2. _____________ I have felt lonely. 
3. _____________ I have felt good about my appearance. 
4. _____________ I have worried about my health. 
5. _____________ I have worried about other people’s attitudes toward me. 
6. _____________ I have felt tired. 
7. _____________ I have had as much energy as usual. 


















The Activities-specific Balance Confidence (ABC) Scale* 
 
Instructions to Participants: 
For each of the following, please indicate your level of confidence in doing the activity without losing 
your balance or becoming unsteady from choosing one of the percentage points on the scale form 0% to 
100%. If you do not currently do the activity in question, try and imagine how confident you would be if 
you had to do the activity. If you normally use a walking aid to do the activity or hold onto someone, 
rate your confidence as it you were using these supports. If you have any questions about answering any 




The Activities-specific Balance Confidence (ABC) Scale* For each of the following activities, 
please indicate your level of self-confidence by choosing a corresponding number from the 
following rating scale: 
 
0% 10 20 30 40 50 60 70 80 90 100% 
no confidence       completely confident 
 
“How confident are you that you will not lose your balance or become unsteady when you… 
1. …walk around the house? % 
2. …walk up or down stairs? % 
3. …bend over and pick up a slipper from the front of a closet floor % 
4. …reach for a small can off a shelf at eye level? % 
5. …stand on your tiptoes and reach for something above your head? % 
6. …stand on a chair and reach for something? % 
7. …sweep the floor? % 
8. …walk outside the house to a car parked in the driveway? % 
9. …get into or out of a car? % 
10. …walk across a parking lot to the mall? % 
11. …walk up or down a ramp? % 
12. …walk in a crowded mall where people rapidly walk past you? % 
13. …are bumped into by people as you walk through the mall? % 
14. …step onto or off an escalator while you are holding onto a railing? % 
15. … step onto or off an escalator while holding onto parcels such that you cannot hold onto the 
railing? % 



























Example script: Identifying facilitators 
 
Goals: 
• Introduce yourself. 
• Review exercises and Giraffe diary entry. 
• Summary of all previous newsletters. 
• Introduction to facilitators.  
• Find out facilitators for exercise. 
 
Script 
I: Hello, good (time of the day). I am Inderpreet Kaur, a researcher at Murdoch University. May I speak to 
(name of the participant)? 
PwMS: … 
I: Is this a convenient time to call you? 
PwMS: … 
I: How are you today?  
PwMS: 
I: How are you going with exercise protocol?  
… 
Any questions regarding the protocol?  
… 
Have you completed your exercise diary? Any questions related exercises? Any difficulties that you feel during 
exercises? 
…. 
Let’s summarise all previous newsletters. 
So far, you’ve learned about the expectations and benefits of exercises. How to monitor yourself to solve 
problems. You know how to set and achieve SMAART goals for your dreams. You’ve learned to increase your 
capability to do exercises and how to control your health habits.  
Any questions regarding this? 
…. (note down, if any) 
In the last newsletter, you have found the things which make it harder for you to do exercise and how to 
overcome them. Now, this newsletter helps you to identify facilitators for exercise adherence. Facilitators are the 
people, places and opportunities that you have around you that make life easier. Have you found anyone or 






Great. This is your facilitator for exercise. (if not) Have you ever found someone or something that helps you 
with anything? 
… ( tell them this is the facilitator for that particular thing)  
Now, you may list down something that supported you to do the GEMS+ exercise program. 
And tell me. (noting down the things) 
…. 
Have you filled the blanks in the paragraph in the newsletter? Please discuss with me. 
If not, please do so and discuss it with  me. 
…  
Any questions till now? 
…. 
All good. So, this was the last phone call regarding newsletters. Please complete the online questionnaire for 
changes in your health status after your four months exercise program. ( this is week 15, complete after week 
16).  
For any queries, please feel free to the study email. Mshealthstudy@murdoch.edu.au. 




















APPENDIX 5- EXAMPLE EXERCISE MANUAL AND GIRAFFE 
PATIENT MANUAL   



































































APPENDIX 6- POST-INTERVENTION AND EARLY FOLLOW-UP 
SAFETY AND FEEDBACK QUESTIONS 
 
Safety questions: 
In the last 4 months/last month, has there been a change in your health resulting in: 
1. Visit(s) or consultation with a health professional (in person or Telehealth)  
• YES, please tell us which type of healthcare professional, the number of visits and reason for visiting. 
Please also let us know was this In Person or Telehealth?  (1) ______ 
• NO (2)  
2. Visit(s) to the hospital. 
• YES, please describe the number of visits and reason for visiting.  (1) _______ 
• NO (2)  
3. Change(s) in your MS symptoms. 
• YES, please describe briefly.  (1) ______ 
• NO (2) 
4. Change(s) in your muscular or joint health.  
• YES, please describe briefly.  (1) ______ 
• NO (2)  
5. A Fall(s) (A fall is defined as an event which results in a person coming to rest inadvertently on the 
ground or floor or other lower level) 
• YES, please describe the number of falls and a brief description.  (1) _______ 
• NO (2)  
6. Any other health status changes not described above. 
• YES, please describe.  (1) ______ 







1. How suitable was the program to your MS symptoms? 
• 0 Not suitable (1)  
• 1 (2)  
• 2 (3)  
• 3 (4)  
• 4 (5)  
• 5 Very suitable (6)  
• No comment (7)  
2. How suitable was the program to your personal fitness level? 
• 0 Not suitable (1)  
• 1 (2)  
• 2 (3)  
• 3 (4)  
• 4 (5)  
• 5 Very suitable (6)  
• No comment (7)  
3. How much would you recommend the program to others like you? 
• 0 Would not recommend (1)  
• 1 (2)  
• 2 (3)  
• 3 (4)  
• 4 (5)  
• 5 Would recommend very highly (6)  
• No comment (7)  
4. How appropriate was the program during the COVID19 pandemic? 
• 0 (not appropriate) (1)  
• 1 (2)  
• 2 (3)  
• 3 (4)  
• 4 (5)  
• 5 (very appropriate) (6)  
• No comment (7) 
5. How appropriate do you think the program would be if delivered as a part of the healthcare system? 
•  0 (not appropriate) (1)  
• 1 (2)  
• 2 (3)  
• 3 (4)  
• 4 (5)  
• 5 (very appropriate) (6)  
• No comment (7) 
6. How satisfied were you with the overall program?  
• 0 (not satisfied) (1)  
• 1 (2)  
• 2 (3)  
• 3 (4)  
• 4 (5)  
• 5 (very satisfied) (6)  
• No comment (7) 





• 0 (not satisfied) (1)  
• 1 (2)  
• 2 (3)  
• 3 (4)  
• 4 (5)  
• 5 (very satisfied) (6)  
• No comment (7) 
8. How satisfied were you with the Giraffe exercise videos?  
• 0 (not satisfied) (1)  
• 1 (2)  
• 2 (3)  
• 3 (4)  
• 4 (5)  
• 5 (very satisfied) (6)  
• No comment (7) 
9. How satisfied were you with logging exercises on Giraffe?  
• 0 (not satisfied) (1)  
• 1 (2)  
• 2 (3)  
• 3 (4)  
• 4 (5)  
• 5 (very satisfied) (6)  
10. How satisfied were you with the exercises you had to do? 
• 0 (not satisfied) (1)  
• 1 (2)  
• 2 (3)  
• 3 (4)  
• 4 (5)  
• 5 (very satisfied) (6) 
11. How satisfied were you with the emailed newsletters? 
• 0 (not satisfied) (1)  
• 1 (2)  
• 2 (3)  
• 3 (4)  
• 4 (5)  
• 5 (very satisfied) (6) 
12. How satisfied were you with the video coaching calls? 
• 0 (not satisfied) (1)  
• 1 (2)  
• 2 (3)  
• 3 (4)  
• 4 (5)  
• 5 (very satisfied) (6) 
13. What did you think of the length of the questionnaire? Too short (1) Just right (2) Too long (3)  
14. Were you happy to answer all the questions we asked you? Yes (1) No (2)  
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